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Abstract 
Metalloproteins were selected by nature to mediate a great and 
extraordinarily heterogeneous class of processes, which are very important 
in biology. This class of biomolecules consists of protein scaffolds and 
prosthetic groups, which contain one or more metal ions linked to the 
polypeptide chain by different types of interaction, either covalent or non-
covalent.  
A mutual relation between metal cofactors and polypeptide chains is 
estabilished, since (i) metal ions can impart a particular trimensional 
folding to the protein, thus influencing its function/s, and (ii) the protein 
matrix is able to modulate the chemical reactivity of metal ions, thus 
selecting one or few functions among all potential activities.  
In this contest, an interesting example is the heme-protein family, in 
which a single prosthetic group, the heme, plays a variety of functions, 
such as dioxygen storage and transport, electron transfer, hydroxylation 
and oxidation of organic substrates, disproportionation of hydrogen 
peroxide, etc..  
Through the study of natural proteins and model systems, it is becoming 
increasingly clear that different proteins are able to optimize the 
environment surrounding the heme-cofactor for the acquisition of 
specific functions. 
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In this respect, this PhD thesis was focused on the study of new models 
of heme-proteins, belonging to the Mimochrome family, developed by the 
Artificial Metallo Enzyme Group in Naples (Lombardi et. al. 2001). 
Generally, these complexes are porphyrin-peptide conjugates, containing 
two peptides, covalently linked to deuteroporphyrin IX, through an amide 
bond between the propionic groups of the porphyrin and the ε-amino 
function of a lysine residue. The two peptide chains are in α-helical 
conformation and cover both planes of the heme, resulting in a helix-
heme-helix sandwich. 
Through an iterative process of design, synthesis, characterization  and re-
design, a penta-coordinated model was developed, Fe(III) Mimochro-
meVI, which  exhibits a peroxidase-like activity (Nastri et al. 2011). 
In order to gain deep insight on the role of the peptide chains in 
modulating the structural and functional properties of Mimochrome VI, 
some point amino acid substitutions in its peptide chains were introduced.  
Here, the rational design, the synthesis and the characterization of five 
analogs of Mimochrome VI is reported (figure  1). These new molecules 
are characterized by peptide substitutions, which were aimed to evaluate 
the role of the Glu2 and Arg10 in both peptide chains (decapeptide, or D, 
and tetradecapeptide, or TD) and the Ser6 in the decapeptide. 
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Figure  1 Scheme of the primary structures of Mimochrome VI and the E2L TD, R10L TD, E2L 
D, R10L D, S6G D analogs. 
 
The newly designed analogues were first screened for their catalytic 
properties. For this purpose, the oxidation reaction of ABTS (2,2’-azino-
bis(3-ethylbenzthiazoline-6-sulphonic acid), through the activation of 
H2O2, was studied. This bottom-up approach allowed to select the 
Fe(III) Mimochrome VI E2L TD analog, whose catalytic efficiency is 
about three fold higher than the horseradish peroxidase (HRP). Moreover, 
Fe(III) Mimochrome VI E2L TD is able to perform about 6000 turn over, 
without bleaching. These very promising results suggest that the site-
specific E2L amino acid substitution on the tetradecapeptide was 
beneficial, thus allowing to select a new peptide-based heme protein 
model with improved catalytic activity. 
The important properties of Mimochrome VI and its analogs afforded us 
in exploring their potentialities in diagnostics and in biosensor 
technologies. 
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The spectroelectrochemical characterization of Fe(III)Mimochrome VI 
immobilized on indium tin oxide (ITO) tridimensional nanoporous films 
was performed in collaboration with the Laboratoire d’Electrochimie 
Moléculaire (LEM) in Paris, under the supervision of Prof. Véronique 
Balland and Prof. Benoit Limoges. 
Nanoporous films of indium tin oxide (ITO) were used as highly sensitive 
transparent 3D-electrodes for time-resolved spectroelectrochemistry. This 
technique was exploited to study the thermodynamics and kinetics of the 
heterogeneous electron transfer, between Fe(III)-Mimochrome VI 
adsorbed within such films, and the electrodic surface.  
The high film loading, due to the columnar structure of metal oxides in 
ITO matrix and Fe(III) Mimochrome VI small dimension, combined with 
the excellent conductivity of this metal oxide film, gave high sensitivity 
measurements. This allowed the simultaneous characterization of the 
heterogeneous one-electron transfer dynamics of the Fe(III)/Fe(II) redox 
couple by cyclic voltammetry and cyclic voltabsorptometry, up to a scan 
rate of few volts per second, with a satisfactory single-scan signal-to-noise 
ratio. The spectroelectroanalytical strategy presented here, opens new 
opportunities for characterizing redox-coupled chemical reactions, within 
redox biomimetic systems and catalysts. It might also be of great interest 
for the development and optimization of new spectroelectrochemical 
sensors and biosensors. 
Based on its small dimensions (3.5 kDa) and its highly efficient 
peroxidase-like catalytic activity, Fe(III)Mimochrome VI is here proposed 
as reporter enzyme for the functionalization of antibodies usable in 
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immunochemical assays.  Human polyclonal antibodies (h IgG) were 
functionalized with this synthetic enzyme, by the use of cross-linkers. 
Conjugates with an enzyme/h IgG ratio up to 13 were prepared. This 
represents a significant result, when compared to commercial immune-
globulins, which are usually linked to 3-4 HRP molecules. The complete 
characterization of the conjugates is in progress, in order to determine 
their immunoreactivity and to develop a marketable immunochemical kit. 
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1. Heme and heme-proteins: structures and functions{ XE 
"1. Heme and heme-proteins\: structures and functions" 
\t "Vedi" }{ TA \l "1. Heme and heme-proteins: 
structures and functions" \s "1. Heme and heme-
proteins: structures and functions" \c 1 } 
Iron-porphyrin complexes, known as hemes, are chemically referred to 
iron ion, usually in the +2 or +3 oxidation states, enclosed in the center of 
a large heterocyclic organic ring (the porphyrin), in which four pyrrolic 
groups are linked together by methine bridges (figure 2).  
Hemes are the prosthetic groups of a large number of metalloproteins and 
they are the most diffused and versatile class of cofactors in biology 
(Chapman et al., 1997). 
Through a long process of evolution, nature selected a plethora of heme 
proteins which are able to carry out such diverse tasks (Holm et al., 1996; 
Reedy and Gibney, 2004). To date, there are numerous documented 
different functions in heme-proteins, ranging from electron transfer 
(Dolphin, 1979; Gray and Winkler, 1996), catalysis (Dolphin, 1979), 
dioxygen transport and storage (Dolphin, 1979), ligand sensing 
(Chan, 2000, 2001), steroid biosynthesis (Privalle, 1983), aerobic 
respiration(Yoshikawa, 2002), photosynthesis (Schäfer et al., 1996) and 
even programmed cell death (Narula et al., 1999) and gene expression 
regulation (Goldberg et al., 1988; Huang et al., 1997). 
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This enormous functional diversity is strictly related to the versatility of 
the heme group and to the protein scaffolds, which creates different heme 
environments, modulating its chemical reactivity. Hence, the main 
features of both the heme cofactors and the polypeptide matrix should be 
examined, when studying heme-proteins.  
1.1 Heme properties 
The identity of the macrocycle chromophore in each type of natural heme 
protein is distinguished by its peripheral β-pyrrolic substituents, as shown 
in figure 2. 
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Figure 2. A. Basic structure of the porphyrin macrocycle: numbering scheme, according to 
IUPAC nomenclature, and functionalization sites. B. Schematic representation of the main heme 
structures found in natural heme-proteins (Reedy and Gibney, 2004). 
The most common heme tetrapyrrole macrocycle is heme b, also called 
protoporphyrin IX or protoheme. It is found in b-type cytochromes, 
globins, cytochromes P-450 and hemesensor proteins. Its chemical 
structure is characterized by methyl groups at positions 3, 7, 12, and 17, 
vinyl groups at positions 13 and 8, and propionates at positions 2 and 18, 
on the macrocycle. 
Generally, the protein scaffolds bind hemes via the combination of the 
axial coordination positions available on the iron, hydrophobic inter-
actions with the heme macrocycle, and polar interactions with the 
propionic acids (Hargrove and Olson, 1996; Hargrove et al., 1996; Reedy 
and Gibney, 2004). 
Heme c is structurally similar to heme b, except that thioether bonds to 
cysteine residues replace one or both of the vinyl groups and covalently 
link the heme macrocycle, to the protein scaffold. Cytochromes c and 
cytochrome f, in which the above mentioned prosthetic group is located, 
typically contain a CXXCH sequence motif, in which the two cysteines 
link to the porphyrin macrocycle and the histidine binds to the encapsula-
ted iron (Reedy and Gibney, 2004).  
Heme a is biosynthesized from heme b, but it is more hydrophobic and 
more electron-withdrawing to the iron ion than its precursor. In fact, 
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heme a is obtained through the conversion of the vinyl group at position 8 
into a hydroxyethylfarnesyl side chain, followed by subsequent oxidation 
of the methyl at position 3 to a formyl group. Heme a is found only in 
terminal oxidases, such as mammalian cytochrome c oxidase (Reedy and 
Gibney, 2004).  
Other less common heme architectures include heme d (Vainshtein et al., 
1986), siroheme (Crane et al., 1995) and chlorocruoroheme (Lemberg and 
Falk, 1951). 
1.2 Protein scaffold in heme-proteins 
How different proteins are able to finely tune the environment of the 
heme cofactor, thus producing different chemistries, has become 
increasingly clear through the study of natural and artificial model systems. 
An increasing number of heme-protein structures was solved through 
high-resolution X-ray crystallography, as well nuclear magnetic resonance 
spectroscopy, contributing to deeply understand their reactivity and their 
structural and electronic properties (Bertini and Luchinat, 1999; Perutz et 
al., 1998; Peterson and Graham, 1998).  
It is now well ascertained that the protein matrix, surrounding the heme 
active site, controls the intrinsic reactivity of the prosthetic group, by 
selecting one reaction as the only or predominant one. The amino acid 
composition and the structural organization of the peptide chain governs 
the properties of the primary (metal coordination geometry, number, type, 
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donor properties of the axial ligands) and the secondary (local dielectric 
constant, hydrophobicity, hydrogen bonding interactions near the active 
site coordination sphere) coordination shells.  
The primary coordination sphere plays important roles in modulating the 
redox potentials, electronic structures, spin states, electron-transfer rates, 
and catalytic properties. Beyond the primary shell, the peptide matrix still 
plays a role in modulating the heme chemical properties. In particular, the 
polarity of the heme micro-environment, which ranges from polar 
(peroxidases) to non-polar (cytochrome P-450), is strictly connected to the 
function of the heme-protein, by controlling the chemistry of the heme. 
Recently, the amino acidic composition at the heme interface was 
investigated and rationalized through bioinformatics (Li et al., 2011). 
Considering a non-redundant data set of 125 heme-proteins, it was 
highlighted that five different amino acids (H, M, C, Y, K) are found to 
serve as axial ligands to the heme iron with histidine as the dominant 
residue (~80%) in both heme b and heme c types (figure 3).  
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Figure 3 Distribution of the axial ligands for heme b (HEM) and heme c (HEC) (Li et al., 2011). 
It was elucidated that there is a natural trend of recreating a hydrophobic 
pocket around the heme. Figure 4 reports the relative frequency of the 20 
amino acids in heme environment. The top five residues with high relative 
frequencies are cysteine (C), histidine (H), phenylalanine (F), methionine 
(M), and tyrosine (Y). Four of the top five (C, H, M, and Y) can serve as 
axial ligands, while the aromatic residues (F,Y and W) play important roles 
in the protein-heme interface, through the stacking interactions with the 
porphyrin. Leucine, isoleucine, and valine, which make hydrophobic 
interactions with the heme ring structure, are also slightly increased over 
the background frequencies. The residues with the fewest occurrences are 
charged residues (D, E and K), suggesting again that the heme binding 
pocket is mainly a hydrophobic environment. 
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Figure 4 Relative frequency of amino acid residues in heme b (HEM), heme c (HEC), and heme b 
plus c (ALL) (Li et al., 2011). 
Moreover, heme-proteins feature a fascinating range of different folding 
architectures. Reedy and Gibney have studied the main structural motifs 
found in heme-proteins in the CATH database (Class, Architecture, 
Topology and Homologous superfamily) and they have hierarchically 
categorized the indentified protein structures by bioinformatics’ tools 
(figure 5). Even if β-sheets (green, 13%) or mixed α/β structures (yellow, 
10%) are not uncommon, the graph clearly shows the current dominance 
of the mainly α-helical (red, 77%) secondary structures in heme proteins of 
known structure (Reedy and Gibney, 2004). 
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Figure 5 Structural classification of natural heme proteins and reference to mainly α-helical 
(myoglobin in red), mainly β-sheet (nitrophorin in green) and mixed α/β (FixL kinase in yellow) 
secondary structure binding sites for heme (Reedy and Gibney, 2004). 
 
It is important to conclude by highlighting that the control of the 
functional specificity by the primary coordination sphere is well under-
stood, on the basis of the selection of such coordinating and, eventually, 
catalysis-involved amino acid residues. However, the contribution of 
medium- and long-range interactions is still not completely rationalized. 
Hence, research activity is still needed, in order to deepen the knowledge 
about the structural and functional properties of this key class of natural 
proteins. 
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1.3 Heme-protein models: from porphyrin to peptide-
porphyrin systems 
The function, the structure and their mutual correlation in natural heme-
proteins was widely studied in literature. However, these protein 
complexity continues to obscure the full description of the factors 
governing the heme properties.  
A large number of artificial model systems are being developed, in an 
attempt to (i) provide further insights for structure-activity relationships, 
(ii) understand the minimal requirements for a specific function, (iii) 
reproduce the properties of the parent natural proteins in smaller 
molecules, and, most importantly, (iv) construct new and tailor-made 
molecules, which can be useful for biomedical, pharmaceutical, biological, 
and environmental applications (Lombardi et al., 2001; Nastri et al., 
1998a).  
The development of low molecular weight heme-protein models started in 
the early 1970s and it was based on the construction around the heme of 
bulky moieties by covalently linking aromatic or aliphatic substituents to 
the porphyrin ring (Collman et al., 1993; Lombardi et al., 2001; Mansuy, 
1993; Meunier, 1992). 
The promising works of Traylor, Collman, Momenteau, and Reed have 
notably contributed to this research area, and they are mainly focused on 
the construction of a penta-coordinated heme-model for the development 
of dioxygen binding molecules (Collman, 1997; Momenteau and Reed, 
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1994; Traylor, 1981; Traylor et al., 1979). In these systems, chelated hemes 
are characterized by a histidine or pyridine ligand covalently bound to the 
propionic group of pyrro-, proto-, meso- and deuteroheme. Some 
representative examples are constituted by the picnic basket, picket 
fence and capped porphyrin systems, where the coordination state of 
the iron (II) is achieved by using hindered substituents on the meso or the 
pyrrole positions of a tetraphenyl porphyrin (TPP) (figure 6). 
 
Figure 6 Schematic representation of (a) picnic-basket porphyrin, (b) picket-fence porphyrin, and 
(c) capped porphyrin as dioxygen binding model compounds (Nastri et al., 1998a). 
These model systems have enabled the comprehension of many structural 
properties of the natural heme-proteins. Despite the important scientific 
contribution deriving from the study of these molecules, they did not 
display any interesting functionality and, hence, they did not find 
widespread practical applications. 
Several metallo-porphyrins, which are soluble in polar organic solvents or 
in water, were developed for applications in catalysis (figure 7).  
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For example, some systems were evolved to mimic the oxygenation 
reaction performed by the cytochrome P450 (Collman et al., 1993; 
Mansuy, 1990; Meunier, 1992). However, these systems show two 
compromising drawbacks, mostly linked to their instability and the 
impossibility of modulating the structure and the function of the synthetic 
molecules. 
 
Figure 7 Schematic representation of substituted porphyrins as cytochrome P450 models (Nastri et 
al., 1998a). 
Peptide-based models have gained enormous importance for the 
identification of the factors governing the heme properties, as they seem 
to better mimic both the structural characteristic sand reactivity of the 
natural systems. Peptide architecture around the heme can serve for 
substrate recognition and to reproduce the chemio-, regio-, and 
stereoselectivity of natural heme-proteins. They display both sufficient size 
and chemical diversity to allow the construction of functional binding and 
catalytic sites (Baltzer, 1999; Baltzer et al., 2001; DeGrado et al., 1999; 
Hellinga, 1996, 1998; Lu and Valentine, 1997; Regan, 1995). Moreover, the 
use of α-helical peptides able to cage the heme group, was and still 
remains the focus of the majority of this research are, because the α-helix 
motif is a recurring structural motif that surround the heme cofactor in 
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numerous natural heme-proteins. Over the years, a large number of helical 
peptide- based heme-protein models have appeared in the literature. They 
differ in structural complexity, and can be grouped into two classes, 
according to the nature of the interactions between the heme and the 
helical peptides: 1) models in which peptide chains incorporate one or 
more heme groups, by non-covalent self-assembling around the heme; 2) 
models in which peptide chains are covalently linked to the heme. 
Excellent examples of non-covalent heme-peptide adducts were reported 
by the groups of DeGrado, Dutton and Haenhel, who used the four-helix 
bundles as protein cages for mono-heme and multi-heme binding (Choma 
et al., 1994; Koder and Dutton, 2006; Koder et al., 2006, 2009; Monien et 
al., 2007; Rau and Haehnel, 1998; Rau et al., 2000, 1998; Robertson et al., 
1994). 
DeGrado, Dutton and co-workers first described de novo designed four-
helix bundle proteins that spontaneously fold in aqueous solution and 
assemble with one or more hemes (Choma et al., 1994; Robertson et al., 
1994). Subsequently,  Dutton and co-workers reached impressive results in 
the design of protein structures, which assemble arrays of cofactors and 
reproduce native-like functions. They used the terms maquettes, French 
word for scale model of something, to refer to these molecular models 
(Koder and Dutton, 2006). The maquettes are based on a sequence with 
high α-helix forming propensities, with residues arranged in the heptad 
repeat pattern, typical of left-handed coiled coils. Such a sequence 
spontaneously assembles into a four helix bundle scaffold, with glutamate 
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and lysine exposed to the solvent, and leucine buried into the interior 
(Koder et al., 2006, 2009). 
An alternative strategy for the design of four-helix bundle with controlled 
topology and housing the heme cofactor, is the chemical synthesis of 
template-assembled synthetic proteins (TASP), first introduced by Mutter 
and co-workers (Mutter and Vuilleumier, 1989). In this strategy, four α-
helices are covalently connected to a cyclic decapeptide template to afford 
a self-assembled four-helix bundle, housing a specific cofactor. This offers 
the advantages that the engineering of anti-parallel four-helix bundle is 
easily accomplished through the covalent attachment of different peptide 
chains onto the template. Haenhel and co-workers used this approach for 
the development of modular organized proteins (named MOP), designed 
to provide a suitable scaffold for the incorporation of a variety of 
cofactors (Rau and Haehnel, 1998; Rau et al., 2000, 1998). 
This section will mainly focus on covalent heme-peptide adducts, which 
are composed by a heme cofactor linked to one or more peptide chains, in 
order to promote stable and geometrically defined structures. Different 
strategies were used for developing covalent peptide porphyrin systems. In 
literature there are both examples of small natural and artificial heme-
protein models. Here, some examples of each class will be reported. 
Microperoxidases (figure 8) are obtained by proteolytic digestion of 
cytochromes c and they are important examples of natural covalent 
peptide porphyrin systems (Aron et al., 1986; Low et al., 1997; Marques, 
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2007; Paléus et al., 1955; Tuppy et al., 1955). Their peptide moiety 
contains the Cys-(Xaa)2-Cys motif and they are covalently linked to the 
heme c via tioether linkages. To date no crystal structure of any micro-
peroxidase was reported. Based on molecular dynamics, it was suggested 
that the peptide retains a conformation very similar to that of the amino 
acid residues of the parent protein (Bushnell et al., 1990; Harbury and 
Loach, 1959). In horse heart cytochrome c the N-terminal residues up to 
Cys-14 are part of an α-helix that terminates with a type III β-turn 
between Cys-14 and Cys-17 (Bushnell et al., 1990). It was proposed that 
MP8 and MP11 suggest that the peptide chain shield the proximal face of 
the porphyrin and the distal face is completely open to solvent. MP8 in 
aqueous solution has its amino acids largely arranged as a torus in a plane 
parallel to the porphyrin (Marques, 2007). Microperoxidases (MP8, MP11 
and other analogs) were shown to be effective catalysts in oxidation and 
oxygenation reactions. However, these mini-enzymes are significantly 
limited by their tendency to aggregate and their low stability under catalytic 
conditions. It is quite important to underline the protective role of the 
peptide matrix of the catalyst, considering that the nude protoporphyrin is 
even less stable than Microperoxidases (Lombardi et al., 2001; Marques, 
2007). 
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Figure 8 Model structure and sequence of Microperoxidases (Marques, 2007). 
The development of the peptide synthesis and design techniques has 
pushed scientists in exploring new possibilities of mimicking the natural 
heme-proteins active site, by developing completely synthetic porphyrin 
peptides systems. 
Benson and co-workers prepared a series of peptide-sandwiched 
mesoheme complexes, indicated as PSMs (Arnold et al., 1997; Benson et 
al., 1995; Liu et al., 1999a; Marques, 2007; Wang et al., 1997; Williamson 
and Benson, 1998). In PSMs the mesoheme II or IX is covalently linked 
to one or two peptide chains via an amide linkage between the propionate 
heme function and the N-ε nitrogen of lysine residues. A His residue in 
each peptide coordinates the heme iron, thus allowing the peptide chains 
to fold above and below the porphyrin ring, giving rise to a sandwich 
structure. The work on PSM molecules clearly confirms that in order to 
build a peptide-based heme protein model with a well-defined three-
dimensional structure, many factors should be taken into account. The 
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covalent attachment of the peptide chains to the porphyrin ring may not 
result in the stabilization of the desired structure. The peptide sequences 
should be accurately designed in order to encompass all the essential 
elements for metal coordination and folding. Benson and co-worker have 
also developed interesting heme-protein models whose structure was 
supported by de novo design approach (Liu et al., 1999b). Through a 
combination of Fe–His coordination, an N-terminal helix capping motif, 
and macrocyclization via disulfide bond formation between two peptide 
chains, they succeeded in selecting peptide-based heme models with extra-
ordinarily high helix content and notable structure stability (figure 9). 
Benson contribution showed that a combination of motifs commonly 
encountered in protein structures can provide considerable structural 
stabilization to heme-protein models built from short peptides. 
 
Figure 9 Peptide sequence and model structureof one diasteromer of the PMS peptide-mediated 
macrocycle (Liu et al., 1999b). 
The Artificial Metallo Enzymes Group (AMEG) in Naples,  where this work 
was carried out, has a long experience in mimicking metalloproteins in 
small peptide-based molecules for the selection of new advanced catalysts. 
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A whole family of synthetic heme-protein models, named Mimochromes, 
was developed and fully characterized (D’Auria et al., 1997; Lombardi et 
al., 1998a, 1998a, 2001, 2003; Nastri et al., 1997, 1998a, 1998a, 2011; 
Ranieri et al., 2010).  
Mimochromes are peptide sandwiched deuteroheme systems, which were 
obtained by miniaturizing natural heme-proteins, in order to partially 
reproduce their structural and functional properties in small and artificial 
compounds. Through a detailed structural investigation, it emerged that 
some natural proteins, like hemoglobin, myoglobin, cytochrome c' and 
cytochrome b562, were characterized  by  a  heme group almost com-
pletely embedded between two relatively small α-helical peptide segments 
(figure 10).  
 
Figure 10 Crystal structure of the Deoxyhemoglobin. Inset: the L88-L96 fragment of the F-helix in 
the β-chain, which was used to construct the Mimochrome I peptide scaffold (PDB entry ID: 
2DN3) (Park et al., 2006). 
 This structural motif was hence used as template to construct the 
prototype of the family, named Mimochrome I. The smallest sequence, 
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required for a complete coating of one face of the heme, was identified in 
a nine-residue peptide, which contains a central His residue to ligate the 
heme iron. Hydrophobic residues were placed to surround the axial 
coordinating residue and to directly face the heme, while the remaining 
five/six helical residues point outward from the heme. Finally, 
deuteroporphyrin was preferred to the more common protoporphyrin IX 
to avoid the possibility of degradation of the sensitive vinyl substituents 
during the synthesis (Nastri et al., 1997). 
Table 1 Peptide sequence of Mimochromes. 
 
 
 Over the time, numerous compounds were evolved in order to (i) 
improve the water solubility and to favor the formation of a unique and 
well defined structure (Mimochrome II and Mimochrome IV) and (II) to 
introduce a structural asymmetry and to stabilize a penta-coordinated 
MIMCHROME R, R1 
I R=R1 Ac-L-A-Q-L-H-A-N-K-L-NH2 
II R=R1 Ac-D-L-S-D-L-H-S-K-K-L-K-I-T-L-NH2 
IV R=R1 Ac-E-S-Q-L-H-S-N-K-R-NH2 
III, V R Ac-D-E-H-K-L-H-S-K-K-R-K-I-T-L-NH2 
R1 Ac-D-E-H-K-L-Y-S-K-K-R-K-I-T-L-NH2 
VI R Ac-D-E-Q-Q-L-H-S-Q-K-R-K-I-T-L-NH2 
R1 Ac-D-E-Q-Q-L-S-S-Q-K-R-NH2 
K= Lysine bound to the deuteroporphyrin 
H= Histidine coordinating the metal centre   Y= Glycine or Serine 
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metal ion, thus introducing catalytic activity (Mimochrome III and 
Mimochrome VI) (table 1). The modulation of the structural and, hence, 
the functional properties of the different analogs was achieved by 
rationally modifying the peptide sequences. Through reiterated cycles of (i) 
design, (ii) synthesis and characterization, (iii) re-design of these molecules, 
it was possible to better and better the properties of the examined 
compounds. This research activity led to the first asymmetric and penta-
coordinated model with a peroxidase-like activity, named Mimochrome 
VI. It will be described in more detail below, being the main object of 
study of the present thesis work. 
 
 
 
 
 
 
 
 
 
 
 
NATURAL AND ARTIFICIAL 
METALLOPROTEINS 
 
 
-25- 
 
CHAPTER I 
1.4 Mimochrome VI: a heme-protein  model with a 
peroxidase-like activity 
The challenge faced up by the project of the molecule Fe (III) Mimochro-
me VI was to create a proximal and a distal site around the heme. This 
compound was re-designed on the basis of the information acquired from 
parent Mimochromes. In particular, the NMR-derived solution structure 
of Co(III) Mimochrome IV (Lombardi et al., 2003) and the model structu-
re of Co(III) Mimochrome II (Lombardi et al., 1998a) were used to 
configure the peptide scaffold of the new molecule (figure 11). The 
sequences of Mimochrome II and IV were combined to construct an 
unsymmetrical five-coordinate mono-histidine model. 
 
Figure 11 Fe(III)-Mimochrome VI model structure and amino acid sequence (Nastri et al., 2011). 
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The asymmetry in both primary and secondary coordination shells was 
realized by combining two peptide chains, different both in length and in 
their amino acid composition. The tetradecapeptide chain, derived from 
the sequence of Mimochrome II, contains a histidine (His6) as a potential 
axial ligand to the metal in the proximal face. The decapeptide chain, 
derived from the sequence of Mimochrome IV, displays a serine (Ser6) to 
create a cavity near the metal site, on the distal face of the heme. In 
analogy with the other Mimochromes, both peptide chains are covalently 
linked to the deuteroporphyrin propionate, through the Lys9 side chains. 
Some substitutions from the sequences of Mimochrome II and IV were 
introduced to further stabilize the secondary and tertiary structures. Inter-
chain ion pairs, between glutamate (Glu2) on one helix and arginine (Arg10) 
on the other helix, were introduced in both peptide chains to stabilize the 
tertiary structure. The positively charged Arg10 and the negatively charged 
Glu2 at the C-terminal and N-terminal ends, respectively, with the op-
posite sign relative to the helix dipole, may also provide stabilization of the 
secondary structure of the two helices. Finally, several glutamines (Gln3,4,8) 
and a serine (Ser7) were introduced in the solvent exposed positions to 
promote water solubility. 
The secondary structure of the tetradecapeptide was designed to adopt a 
short helical conformation (residues 1–9), a loop γβD (residues 10 and 11) 
and a short β-strand (residues 12–14) that folds back (through the loop) to 
interact with the helical part. 
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The decapeptide chain was designed to adopt a helical conformation from 
residue 1 to residue 8.  
The tertiary structure can be described as a the sandwich,  characteristic of 
all Mimochromes, in which: 
• the two peptide chains embrace the metalloporphyrin; 
• the helical segments are antiparallel to each other 
• the helix axes are about parallel to the porphyrin plane.  
All the spectroscopic and functional properties, deriving from its 
characterrization, describe Fe(III) Mimochrome VI as a very promising 
heme–protein model and an efficient biocatalyst. In fact, it displays a 
typical peroxidase-like catalytic activity towards different reducing 
substrates. Fe(III) Mimochrome VI shows a catalytic efficiency in the 
oxidation of ABTS (2,2’-azino-di(3-ethyl-benzothiazoline-6-sulfonic acid) 
and guaiacol, which is comparable to that of native horseradish peroxidase 
(table 2Table 3). Moreover, Fe(III) Mimochrome VI converts phenol to 
4- and 2-nitrophenol in the presence of NO2 and H2O2 in high yields.  
Concerning the catalytic properties, it was demonstrated the important 
role of both the peptide chains, in modulating the Fe(III) Mimochrome 
VI properties. In fact, the so-called mono-adduct, which lacks the distal 
decapeptide chain, has showed a higher kcat than the value displayed by the 
full Fe(III) Mimochrome VI, in the same experimental conditions (table 
2). This can be interpreted in terms of a faster access of the substrate and 
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co-substrate to the iron site when the decapeptide chain is missing. At the 
same time, Fe(III) Mimochrome VI mono-adduct shows lower apparent 
affinity towards the substrate and co-substrate. This indicates that the 
decapeptide chain in Fe (III) Mimochrome VI may assists their binding. 
Most interestingly, the mono-adduct is more susceptible to oxidative 
degradation, as shown by the much lower number of turnovers that is able 
to perform, with respect to Fe(III) Mimochrome VI. This is a clear 
evidence of the protective effect to degradation exerted by the decapeptide 
chain, which represents a very interesting property of this kind of 
molecule. 
Table 2 Catalytic parameters in the oxidation of ABTS  (AH2) through H2O2 activation. 
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Table 3 Catalytic parameters in the oxidation of guaiacol (AH2) through H2O2 activation. 
 
 
Finally, the efficient binding of small ligands, such as carbon monoxide, 
imidazole and nitric oxide can be easily detected by discrete spectroscopic 
modifications of the Fe(III) and Fe(II) Mimochrome VI  species, 
respectively. 
These results demonstrate that small synthetic peptides can impart high 
enzyme activities to metal cofactors, and anticipate the possibility of 
constructing new biocatalysts tailored to specific functions (Nastri et al., 
2011). 
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2. The horseradish peroxidase: a versatile tool for 
biotechnology 
Peroxidases have a considerable potential for application in many different 
areas. Their commercial application is especially well established in analytical 
diagnostics (e.g. biosensors and immunodetection technologies). Due to its 
characteristics, the horseradish peroxidase (HRP) is quite adapt to successful 
use in analytical systems (e.g. ﬂexibility, stability, sensitivity in range of 
analyte detection and availability in pure form at reasonable cost) (Azevedo 
et al., 2003) 
 
2.1 HRP: overview on functional and structural main 
features 
Horseradish peroxidase (HRP) was discovered in 1810 by Planche, who 
observed that soaking a piece of horseradish roots into a tincture of 
guaiacum, resin led to the development of a strong color (Planche, L. A. 
1810). The molecule responsible of that phenomenon was precisely HRP, 
which would have become the most widely studied of all peroxidases 
(Johannes Everse et al., 1991). 
It is now accepted that peroxidases occur as a large family of isoenzymes. 
Horseradish peroxidase isoenzyme C, the most diffused and studied of the 
family, comprises a single polypeptide of 308 amino acid residues, the 
sequence of which was determined by Welinder in 1976 (figure 12) 
(Azevedo et al., 2003; Welinder, 1976). 
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Figure 12 The amino acid sequence of HRP C (Welinder, 1976). 
The N- terminal residue is blocked by pyroglutamate and the C- terminus is 
heterogenous, with some molecules lacking the terminal residue, Ser308. 
There are 4 disulphide bridges between 11–91, 44–49, 97–301 and 177–209 
cysteine residues. Nine N-glycosylation sites can be recognized in the 
primary sequence from the motif Asn-X-Ser/Thr. The HRP C 
carbohydrate profile is heterogeneous, and it is mainly constituted by 
branched hepta-saccharides, many minor glycans, N-Acetylglucosamines 
and several mannose residues. The total carbohydrate content of HRP C is 
usually 18-22% and it depends on the source of the enzyme (Veitch, 2004; 
Yang et al., 1996). 
HRP C contains two types of metal center, Fe(III) protoporphyrin IX and 
two calcium atoms (figure 13). Both are essential for the structural and 
functional integrity of the enzyme.  
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At the proximal side, the heme group is attached to the enzyme at His170 by 
a coordinate bond. The second axial position (on the distal side of the heme 
plane) is unoccupied in the resting state of the enzyme, but available to 
hydrogen peroxide during the enzyme turnover. Small molecules, such as 
carbon monoxide, cyanide, ﬂuoride and azide, are able to bind to the heme 
iron atom at this distal site.  
The two calcium ions are located at the heme distal and proximal positions 
and they are both hepta-coordinated by a combination of amino acids side 
chains (Asp carboxylates, Ser and Thr hydroxyl groups), backbone carbonyls 
and water (Veitch, 2004). 
The structure of the enzyme is largely α-helical, although there is also a small 
region of β-sheet, in purple and yellow, respectively in figure 13. There are 
two domains, the distal and the proximal, between which the heme group is 
located. (Gajhede et al., 1997; Veitch, 2004). 
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Figure 13 Three-dimensional representation of the X-ray crystal structure of horseradish peroxidase 
isoenzyme C (PDB entry ID: 1H5A). Inset: Key amino acid residues in the heme-binding region 
(Veitch, 2004). 
Most reactions catalyzed by HRP C and other horseradish peroxidase 
isoenzymes can be expressed by the        
Equation 1, in which AH2 and represent a reducing substrate and its 
radical product, respectively. Typical reducing substrates include aromatic 
phenols, phenolic acids, indoles, amines and sulfonates. 
       Equation 1 
The mechanism of catalysis was extensively investigated (Berglund et al., 
2002; Poulos and Kraut, 1980; Veitch and Smith, 2000) and is schematically 
described in figure 14. 
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The first step in the catalytic cycle is the reaction between H2O2 and the 
Fe(III) resting state of the enzyme to generate compound I, a high oxidation 
state intermediate, comprising Fe(IV) oxo-ferryl center and a porphyrin-
based cation radical. A transient intermediate (compound 0) formed prior to 
compound I was detected in reactions between HRP C and H2O2 at low 
temperatures and described as Fe(III)-hydroperoxy complex (Poulos and 
Kraut, 1980).  
In formal terms, compound I is two oxidizing equivalents above the resting 
state. The first one-electron reduction step requires the participation of a 
reducing substrate and leads to the generation of compound II, Fe(IV) oxo-
ferryl species that is one oxidizing equivalent above the resting state. Both 
compound I and compound II are powerful oxidants, with redox potentials 
estimated to be close to +1V. The second one-electron reduction step 
returns compound II to the resting state of the enzyme (Veitch, 2004).  
The formation of a third species, named compound III, was reviewed. This 
intermediate is best described as a resonance hybrid of iron(III)-superoxide 
and iron(II)-dioxygen complexes. A high-resolution crystal structure of 95% 
pure compound III published recently shows dioxygen bound to heme iron 
in a bent conformation (Berglund et al., 2002).  
A mechanism for the reduction of bonded dioxygen species to two 
molecules of water was proposed. This mechanism involved four successive, 
one-electron, reductions with the concomitant uptake of a proton, from 
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Compound III to the ferrous HRP, via the intermediate forms of 
Compound I, Compound II and ferric HRP. 
 
 
Figure 14 The five oxidation states of HRP during  the catalytic cycle (Berglund et al., 2002). 
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2.2 HRP in biosensors development 
Biosensors are becoming more and more important tools in medicine, 
quality control, food and environmental monitoring, and research (Chaubey 
and Malhotra, 2002). IUPAC defines chemical and biological sensors as a 
“device that uses specific biochemical reactions, mediated by isolated enzymes, 
immunosystems, tissues, organelles or whole cells, to detect chemical compounds usually by 
chemical, optical or thermal signals“ (Thévenot et al., 1999, 2001) 
As indicated in figure 15, biosensors usually contain two basic components, 
connected in series:  
 
 
 a bioreceptor, which is a biomolecule, or a 
bio-inspired molecule, able to specifically 
recognize the analyte; 
 a physicochemical transducer, which 
transforms the physicochemical signal, 
deriving from the recognition event, into a 
easily measurable signal (Thévenot et al., 
2001).  
 Figure 15 Scheme of a general 
biosensor arrangement. 
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Both elements act in concert and let to detect and quantify specific 
molecules in a complex samples, thanks to the high recognition specificity 
of the bio-molecules and the sensitivity of the transduction mechanism 
(Collings and Caruso, 1997).  
According to the measuring principle of the transducer, biosensors are 
divided into electrochemical, optical, calorimetric, acoustic, evanescent 
wave, surface plasmon resonance and piezoelectric (Collings and 
Caruso, 1997; Mello and Kubota, 2002).  
Electrochemical biosensors, the most widely used, are based on the 
generation of an electrochemical signal during the interaction of the 
biological component with the analyte. Depending upon the electrochemical 
property measured, they can be further divided into amperometric (in 
which redox processes provide current ﬂow at constant potential), 
potentiometric (potential changes at constant current, using generally ion-
selective electrodes) and conductimetric (conductance changes in the ionic 
environment) biosensors (Azevedo et al., 2003; Chaubey and Malhotra, 
2002; Griffiths, 1993). 
Redox-active metalloproteins are usually components of electro-chemical 
biosensors. When using an enzymatic recognition element, the transduction 
and the recognition elements match in the same molecular mechanisms, 
often providing an important amplification of the signal, due to the enzyme 
turn over.  
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Since HRP is capable of reducing H2O2 and also some organic peroxides, 
HRP-based biosensors can be used to control and monitor these peroxides, 
in pharmaceutical, environmental and dairy industries (Somasundrum et al., 
1996), in bleaching operations in the textile and paper industries 
(Gündoğan-Paul et al., 2002), in air and water ozonisation processes and in 
food products(Mulchandani and Rudolph, 1995). The principle of detection 
is rather simple and it is schematically represented in figure 16 A. The 
peroxide oxidizes the enzyme and the electrode reduces it back to its native 
form. It is possible to measure a reduction current, which is proportional to 
the peroxide concentration (Chaubey and Malhotra, 2002).  
If HRP is coupled with a hydrogen peroxide producing oxidase (figure 16 
B), then the system becomes sensitive to the oxidase substrate, enabling the 
control and monitoring of a wide range of analytes such as glucose (Yabuki 
et al., 2001), ethanol (Azevedo et al., 2005), cholesterol (Bon-giovanni et al., 
2001; Peña et al., 2001), lactate (Serra et al., 1999), amino acids (Domínguez 
et al., 2001), and many others. 
 
Figure 16 Schematic representation of HRP-based biosensors. A. HRP modified electrode for the 
detection of H2O2. B. bi-enzymatic system, incorporating HRP and Oxidase. 
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Hydrogen peroxide is not the only possible substrate, whose processing can 
be electrochemically detected. Recently, an amperometric flow biosensors 
for cyanide was developed by using HRP-adsorbed carbon-felt (CF)(Wang 
and Hasebe, 2011). Hu and Li  reported the bio-electrocatalytic activity of 
HRP-electrodes for the O2 reduction (Liu et al., 2006; Zhang et al., 2004). 
The produced compound III is directly reduced to the ferrous-HRP via 
ferric-HRP (figure 14Figure 17). As a result, the dissolved O2 is reduced to 
H2O, which leads to a bio-electrocatalytic cathodic current appearance.  
Cyanide is well known inhibitor of peroxidase activity, and binds to the sixth 
coordination position of heme-iron. Since this binding-site is same of O2, 
the cyanide competitively inhibits the formation of compound I. Wang and 
Hasebe demonstrated the reversible inhibition of the HRP electrocatalytic 
activity, which was easily detected by electrochemistry. This represented a 
promising perspective for the set-up of a new biosensor for the quantitative 
analysis of cyanide in wastewater, alternative to the conventional and more 
expensive and time-consuming methods (e.g. colorimetric, potentiometric 
and chromatographic). 
 
Figure 17 Schematic representation of HRP-based biosensor for cyanide detection. 
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2.3 HRP as reporter enzyme in immunodetection 
HRP is widely used as an enzyme label in medical diagnostics and research 
applications. Covalent conjugates of proteins, antibodies and other 
molecules with HRP are useful and versatile tools for ultra-sensitive 
detection in immunoassays, such as enzyme-linked immunosorbent assays 
(ELISA) and immuno-histochemistry (IHC) (Azevedo et al., 2003). 
The term immunoassay describes a wide range of tests used to specifically 
detect and quantify analytes. They are based on the formation of 
immunocomplexes, between an antigen and a specific antibody. The 
detector system is usually an enzyme (e.g. HRP), which is covalently bound 
to the antibodies. Immunocomplexes are quantified by measuring a 
colorimetric, fluorescent or chemiluminescent signal, deriving from the 
enzymatic reaction. The immunological component brings the detection 
specificity, while the enzyme component gives the analytical sensitivity 
(Ashley et al., 2008). 
Even though ELISA and IHC techniques are quite similar for the 
immunodetection approach, they differ for several aspects. 
The first difference between ELISA and IHC is the origin of the sample. 
Usually ELISA are realized on liquid samples (e.g. biological fluids, but even 
water or food samples), while IHC is realized on histological samples (e.g. 
biopsies). Consequently, the specimen preparation before the immunodetec-
tion is quite different. 
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A typical ELISA immunoassay involves:  
 the immobilization of an antigen onto a solid support (e.g. multi-well 
polystyrene plate, bead, membrane):this step can be realized directly 
by chemical adsorption (figure 18 C) or via a capture antibody 
(figure 18 D,E) 
 the recognition of the analyte with a specific antibody: the antigen can 
be detected directly, by a primary enzyme-conjugated antibody 
(figure 18 C,D), or indirectly, by a primary recognition antibody and 
a secondary enzyme-conjugated antibody (figure 18 E) 
 
IHC requires proper tissue collection, fixation and sectioning, in order to 
preserve cell and tissue morphology and the antigenicity of target epitopes. 
After fixation, usually in paraformaldehyde, samples are sectioned and slices 
are mounted on microscope slides. Even in this case the detection can be 
direct (figure 18 A) or indirect (figure 18 B) 
HRP is well suited for the preparation of enzyme-conjugated antibodies and 
antigens, due to its relatively good stability and medium molecular size, but 
especially for its ability to yield chromomeric products with high turnover 
number (Azevedo et al., 2003).  One survey of HRP use stated that this 
enzyme is incorporated in about 80% of all antibody conjugates for different 
purposes (Hermanson, 2008). Moreover, the availability of substrates for 
colorimetric, ﬂuorimetric and chemiluminescent assays provide numerous 
NATURAL  AND SYNTHETIC PEROXIDASES IN 
BIOTECHNOLOGY 
 
-42- 
 
CHAPTER II 
detection options (Duffy and Murphy, 2001; Huy et al., 2005; Kuroda et al., 
2001; McInvale et al., 2000; Roda et al., 2002; Yavo et al., 2001).. 
 
Figure 18 Schematic representation of ELISA and IHC techniques 
2.4 Limits of HRP in biosensors and immunoassays  
As previously discussed HRP, and other natural enzymes were widely used 
in biosensors and immuno-conjugate development. However, the relatively 
high dimensions of HRP (and generally of natural proteins) can cause a 
series of disadvantages in both fields of biotechnological applications. 
Concerning biosensor development, the main problems that can be 
encountered with the use of natural enzymes and metalloproteins are: 
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 the variable orientation of the redox centers and the denaturation of 
the proteins, upon the immobilization on the sensor surface, 
 the lack of efficiency of electron transfer pathways (ET), due to the 
polypeptide extended moiety, that can shield or slow down the ET, 
 the limited density of redox-active centers per surface unit. 
In order to promote a well-organized arrangement of the redox centers and 
to limit the proteins denaturation, several self-assembled monolayers (SAM) 
were developed, aimed to mediate the indirect binding on the sensor surface 
(Samanta and Sarkar, 2011). Briefly, SAMs are organic molecules (thiols, 
sulphides, cyanides, alkylphosphonates and alkane-thiols), which are able to 
form spontaneously organized layers by chemisorptions (Nuzzo and Allara, 
1983). They were widely investigated in literature, as they provide a facile 
means of defining the chemical composition and structure of a fun-
ctionalized surface. Through proper selection of terminal functional group, 
specific surface/solution interactions (covalent, electrostatic or hydro-
phobic) can be exploited to immobilize molecules at an interface. SAMs can 
be prepared and characterized using various methods (Arya et al., 2009). 
Concerning the ET pathways, a better electrochemical biosensor 
performance was obtained in second generation biosensors, by 
introducing a mediator in the analytical system. These are small artificial 
electron transferring agents, that shuttle electrons between the redox centers 
and participate in the reaction with the biological component, thus speeding 
the ET (Cass et al., 1984; Chaubey and Malhotra, 2002, 2002; Parra et al., 
2006).  
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Subsequently, third generation biosensors were developed, in order to 
construct electrochemical systems with superior selectivity, stability and 
durability. These devices exploit the unmediated direct electron transfer 
(DET) between redox-active metalloproteins and the transducer.  An 
attractive feature of systems based on direct electron transfer is the 
possibility of modulating the properties of the analytical device, by using 
protein modification with genetic or chemical engineering techniques. 
Efficient direct electron transfer reactions were reported for a restricted 
number of redox enzymes, mostly. Nevertheless, several studies, based on 
heme-proteins adsorbed or immobilized on various electrodes, still showed 
that high-molecular weight enzymes are not amenable to direct electrical 
communication with the electrode. In fact, the heterogeneous ET between 
the electrode and the redox-active center may be not favored, due to 
unavailability of efficient ET routes, also due to partial or full protein 
unfolding/denaturation on the electrode surface. 
Concerning the immunoconjugate production, it is important to underline 
that commercially available HRP-conjugates are limited to one to three HRP 
molecules per antibody (Ab). This value is mainly due to the steric 
hindrance of HRP during the conjugation reactions and represents the limit 
for maintaining the functionality of the conjugate. This molar ratio of 
conjugation is effective in routine experiments, but it may lack the sensitivity 
required for detecting targets present in low picogram to femtogram 
amounts. In conventional ELISA kits, this limit is often  solved by using 
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additional steps to amplify the signal: these methods increase the cost of the 
assay and the number of steps, that must be optimized each time. 
Several approaches to increase ELISA sensitivity are reported in literature, 
involving the use of biotin-streptavidin HRP-Ab (Nara et al., 2008) and 
bionanocapsule-based HRP-Ab systems (Iijima et al., 2010), HRP-Ab 
functionalized nanoparticles (Zhou et al., 2011) and HRP-Ab functionalized 
carbon nanotubes (Chunglok et al., 2011). Generally, these different 
approaches share the same target: to increase the number of enzyme 
molecules per molecule of antibody, in order to create a probe for the 
analytes detection with better performances and measurements with higher 
sensitivity.  
On the basis of the previous considerations, it emerges that increasing the 
sensitivity of the measurements achievable by electrochemical biosensors 
and immunochemical techniques represents still now a very challenging 
scientific field, to whom we have referred during the realization of this 
research project. 
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The goal of this PhD project is the development of new biomimetic 
catalysts, based on heme-enzymes, for applications in diagnostic and 
biosensor technology. 
As outlined in the previous paragraph, the technology used to date still 
suffers of several problems, mainly  derived from the high dimension and 
quite low stability of natural metalloenzymes. 
Therefore, this project aims to exploit the remarkable catalytic activity of 
Mimochrome VI (see 1.4 Mimochrome VI: a heme –protein model with 
a peroxidase-like activity) as starting point for the development of new 
bio-inspired devices.  
The project, which lays at the interface between chemistry, biochemistry and 
biology, takes advantages from the use of different methodologies and 
techniques, such as metalloprotein design, chemical synthesis, 
spectroscopic, structural and catalytic characterization, immobiliza-
tion procedures on solid surfaces and cross-linking with biomolecules 
(figure 19). 
All these methodologies have contributed to accomplish the two main 
objectives of the project. 
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 Improve the catalytic performance of Mimochrome VI. 
Through a re-design procedure and computational techniques, it is 
possible to introduce some point amino acid substitutions, in order to 
verify their role in the modulation of the heme-model properties. In 
particular, five Mimochrome VI analogs were designed, synthesized and 
characterized during the research activity, here reported. Trough this re-
design/characterization approach it was possible to select new catalysts, 
with improved functional properties. 
 Evaluate the potential of Mimochrome VI for the development of 
bio-inspired devices. 
The use of Mimochrome VI is here proposed for the development of 
new and advanced biosensors and immunochemical assay. By 
exploiting the small dimensions and its high catalytic efficiency, it was 
possible to increase both biosensors surface coverage and antibodies 
conjugation ratio. This approach will be crucial for a considerable signal 
amplification and hence, for the development of more sensitive 
immunochemical assays and biosensors. 
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Figure 19 Representation of how basic and applied research, taking advantages of several techniques 
and methodologies, at the interface of biology, biochemistry and chemistry, are applied in this PhD 
project. 
 
  
 
  
 
 
 
 
 
 
Results and 
discussion 
 
 
 
 
CHAPTER III: DEVELOPING NEW HEME-PETIDE 
CATALYSTS   
DEVELOPING NEW CATALYTIC PEPTIDE-
BASED HEME MODELS 
 
  -48- 
 
CHAPTER III 
3. Mimochrome VI and its analogs: design and synthesis 
of new catalysts 
Fe(III) Mimochrome VI is an asymmetric and penta-coordinated heme-
protein model with a peroxidase-like catalytic activity. As previously 
described, this peptide-deuterporphirin adduct was designed on the basis 
of the information acquired from the structural and functional 
characterization of the previous models. Based on the results obtained 
through the analysis of several Mimochromes, the central role of the 
peptide moiety in their structure/function relations progressively 
emerged. In fact, the amino acid composition of the peptide sequences 
can be designed in order to: 
 impart typical secondary (α-helical) and tertiary (sandwich helix-
heme-helix) structures (D’Auria et al., 1997; Lombardi et al., 1998b; 
Nastri et al., 1997, 1998b); 
 stabilize a symmetric and hexa-coordinated chemical environment 
to the heme (Lombardi et al., 2003; Nastri et al., 1998b); 
 select a stereochemically stable structure (Lombardi et al., 2003); 
 modulate the redox properties of the heme (Del Gatto, 2007; 
Lombardi et al., 2003; Ringhieri, 2010); 
 improve the water solubility and stabilize an asymmetric and penta-
coordinated peptide-based heme-model (Nastri et al., 2011). 
Concerning the role of the peptide moiety in Fe(III)Mimochrome VI, its 
implication in the structural and functional properties of the molecule was 
described in the introduction (see 1.4 Mimochrome VI: a heme-protein  
model with a peroxidase-like activity). Here, it is important to focus on 
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the R10 and E2 residues, which are placed in both tetradecapeptide and 
decapeptide chains, and the Ser6 on the decapeptide chain (figure 20).  
In the model structure, the R and E residues are involved in the 
stabilization of the α-helix, via charge-dipole interactions, and in the 
tertiary sandwiched structure, by the formation of inter-chain ion pair.  
The S6 is placed in the decapeptide chain to create a micro cavity in the 
proximal site of the deuteroheme. The serine residue was selected in order 
to facilitate the access of small ligands and substrates, thanks to its small 
and space-saving side chain. This residue, unable to interact with the metal 
ion, was placed in the middle of the decapeptide chain, thus stabilizing a 
penta-coordinated state of the heme. Further, the hydroxyl group in the 
side chain is supposed to interact via hydrogen bonds with H2O2 during 
the first step of the catalytic cycle, and hence it can improve the affinity 
towards this substrate. 
In order to verify the role these five amino acid residues (E2, S6 an R10 in 
the decapeptide and E2 and R10 in the tetradecapeptide) in the structural 
and functional properties of Fe(III) Mimochrome VI, it was decided to 
introduce single point substitutions and to verify their effect on the cata-
lysis. Five analogs of Fe(III) Mimochrome VI were designed, synthesized 
and characterized for this purpose (figure 21). 
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Figure 20 Model structure and sequence of Fe(III) Mimochrome VI molecule: in evidence the 
inter-chain ion pair between E2-R10 (circle) and the S6 on the distal side of the heme (arrow).  
 
Figure 21 Scheme of peptide sequences of Mimochrome VI analogs. The amino acid substitution 
on the tetradecapeptide (TD) and decapeptide chain (D) are pointed out. 
The charged residues (E2 and R10) were substituted with the hydrophobic 
leucine (L), in order to eliminate their ion-pair interactions. These 
substitutions feature the E2L TD, E2L D and R10L TD, R10L D analogs 
of Mimochrome VI. The S6 was replaced by a glycine (G), which has still a 
small and non-coordinating side chain and lacks the hydroxyl group, 
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which is supposed to mediate the H2O2 delivery to the active site of the 
mini enzyme. This substitution characterizes the S6G analog. 
Fe(III) Mimochrome VI and its five analogs were prepared, following the 
same synthetic strategy used for the other Mimochromes (Nastri et al., 
2011). Peptide chains were synthesized in solid phase, by using 9-
fluorenylmethoxycarbonyl (Fmoc) protection strategy. The selective 
deprotection from (4-methoxyphenyl)diphenylmethyl group (Mmt) of 
Lys9 residues on the two chains is required before their cleavage from the 
resin. In this way, it is possible to obtain the peptides with the free Lys9 
and all other residue side-chains still protected (figure 22).  
 
Figure 22 Selective deprotection of Lys9 side chain of decapeptide and tetradecapeptide side chain 
This aspect is important for the selective coupling to the 
deuteroporphyrin  IX, which was carried out in solution. In order to 
optimize the hetero-dimer formation (TD-deuteroporphyrin IX-D) and to 
avoid undesired byproducts (TD-deuteroporphyrin IX-TD or D-
deuteroporphyrin IX-D), the synthesis was continued, by coupling first 
one peptide to the deuteroporhyrin IX and subsequently, the so-called 
monoadduct was bound to the other peptide chain. In particular, to limit 
coupling of the first peptide to both propionate groups, it was slowly 
added to the solution containing the porphyrin. In such way, the 
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porphyrin is in excess and reacts with all peptide molecules in solution, 
thus favoring monoadduct formation. 
Once obtained the di-substituted product, the remaining protecting 
groups were removed from both peptide chains by treating with trifluoro-
acetic acid. Thus, the iron ion was inserted in the free base porphyrins, by 
following the acetate method (Buchler, 1979). The products were finally 
purified by reverse-phase HPLC and their identity is confirmed by LC-MS 
analysis. For more detailed description of protocols and synthetic results, 
please refer to materials and methods section. 
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3.1 Mimochrome VI and its analogs: functional 
characterization 
The functional properties of the five analogs of Fe(III) Mimochrome VI 
were investigated in order to understand the effects of the peptide amino 
acid composition on the catalytic properties.  
In particular, the experiments here presented were carried out in order to 
assess the ability of these compounds to activate H2O2 for the oxidation 
of a reducing substrate: ABTS or 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulphonic acid) (figure 23). 
 
Figure 23 Chemical structure of ABTS and oxidation reaction with H2O2. 
ABTS is commonly used as a substrate with hydrogen peroxide for the 
kinetic study of peroxidase enzymes, since it can be efficiently oxidized in 
a mono cationic radical form (ABTS+●) (Childs and Bardsley, 1975; 
Savenkova et al., 1998). In fact, the formal reduction potential of ABTS is 
high enough let it to act as an electron donor for the reduction of oxo and 
peroxo species (Bourbonnais et al., 1998) The product of the reaction 
exhibits a green color and a λMAX at 660 nm and its formation can be easily 
detected by spectrophotometric measurements. 
The analysis of  the  kinetic data by Michaelis-Menten fitting of the 
experimental points provides the following catalytic parameters: 
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 , which is the reaction rate at saturating concentration of 
substrate: at low  substrate concentrations, the initial rate increases 
almost linearly, while at saturating substrate concentrations, v0 
achieves the maximum value ( ); 
  is the Michaelis-Menten constant, representing the substrate  
concentration at which the half of the  is reached.  It  
represents the enzyme apparent affinity for substrates; 
  which is the catalytic constant (or turnover 
number) and is defined as the maximum number of molecules of 
the substrate that an enzyme can convert to product, per catalytic 
cycle, per unit of time; 
 , which is the catalytic efficiency and gives information on 
the catalytic activity at low substrate concentration. 
The kinetic parameters can be determined by studying the dependence 
towards both substrates and by analyzing the experimental data with a 
two substrate Michaelis-Menten kinetic model (equation 2): 
 
Equation 2 
 
where:  
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  is the enzyme concentration, which is supposed to be con-
stant and not inactivated at the initial time (t0);  
  is the catalytic constant;  
  and  are the Michaelis-Menten constants for ABTS and 
H2O2, respectively; 
  and  are the ABTS and H2O2 concentrations, respectively.  
In order to perform a first screening of the functional properties of the 
afore mentioned molecules, their catalytic activity was studied in the same 
conditions used for Fe(III) Mimochrome VI (100 mM phosphate buffer 
pH 6.5, 50% (v/v) TFE, at fixed catalyst concentration and variable 
substrates concentration). Experimental data were compared to those 
obtained for the kinetic characterization of HRP(100 mM citrate buffer 
pH 4.6 and 7) and two other peptide-based heme-protein models (MP-8 
and MP-11). 
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3.1.a Catalytic characterization of  Mimochrome VI 
analogs: effects of tetradecapeptide modifications 
In order to determine the kinetic properties of Fe(III) Mimochrome VI 
E2L TD, R10L TD analogs, the dependence towards both substrates 
(ABTS and H2O2) was analyzed (figure 24).  The concentration of the 
catalyst was fixed at 2.0∙10-8 M. For the analysis of the dependence 
towards the oxidizing substrate, ABTS concentration was fixed (1.0∙10-1 
M), while different H2O2 concentration, in the range of 1.0∙10
-4-2.0∙10-2 M 
were explored. When studying the dependence towards the reducing 
substrate, H2O2 concentration was fixed (2.0∙10
-2 M for E2L TD and 
1.0∙10-2 M for R10L TD), while ABTS was varied (5.0∙10-6-1.0∙10-4 M).  The 
kinetic parameters obtained by fitting the experimental data with the 
equation 2 are summarized in  
table 4. 
3.1.b Catalytic characterization of  Mimochrome VI 
analogs: effects of decapeptide modifications 
The effects of the decapeptide substitutions (E2L D, R10L D and S6G D) 
were studied by the same approach (figure 25). The concentration of the 
catalyst was fixed at 2.0∙10-7 M, because of their lower catalytic activity. 
Experiments were carried out (i) at steady ABTS (1.0∙10-1M) and variable 
H2O2 concentrations (1.0∙10
-4-2.0∙10-2 M) and, vice versa, (ii) at constant 
H2O2 (50 mM for M6 E
2L D, 20 mM for R10L D, 50 mM for S6G D) and 
different ABTS concentrations (5.0∙10-6-1.0∙10-4M). The kinetic parameters 
obtained by fitting the experimental data with the equation 2 are 
summarized in  
table 4. 
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Figure 24  Kinetic study of tetradecapeptide-modified Mimochrome VI analogs. Initial rates of 
ABTS oxidation at various H2O2  concentrations and vice versa. The data were fitted according to 
equation 2 for a two substrates Michaelis-Menten model. 
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Figure 25 Kinetic study of decapeptide-modified Mimochrome VI analogs. Initial rates of ABTS 
oxidation at various H2O2  concentrations and vice versa. The data were fitted according to 
equation 2 for a two substrates Michaelis-Menten model. 
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3.1.c Catalytic characterization of  Mimochrome VI 
analogs: analysis of the turnover numbers 
One  important parameter to focus, in order to gain more insight in the 
functional properties of these molecules, is the comparison of their  
turnover numbers (TON). TON are considered as the number of moles 
of substrate that a mole of catalyst can convert, before inactivation. In 
order to assess the turnover number, the enzymatic activity was studied at 
fixed ABTS (1.0∙10-4M) and H2O2 (3.0∙10
-3M) concentrations and at 
different  enzyme concentration, in the range from 2.0∙10-8 to 1.0∙10-8M 
(figure 26). The red kinetic curves reported in the figure represent the 
minimum enzyme concentration at which it is still possible to oxidize all 
the ABTS present in solution, which can be deduced by the achievement 
of the plateau of the ABTS●+ absorbance (Abs660=1.1). These concentra-
tion values were used to calculate the TONs of the analogues, which are 
reported in  
table 4. 
 
3.1.d Catalytic characterization of  Mimochrome VI 
analogs: pH dependence 
The role of the of pH on the activity was also examined.. The pH profile 
of the v0 for the ABTS
+• formation is characterized by curves with a 
maximum activity at pH 6.5 (figure 27). It seems that the amino acid 
substitutions do not affect the optimum pH of the oxidizing reaction 
towards ABTS. 
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Figure 26 Kinetic experiments at varying enzyme concentration to determine the TON values for 
the five Fe(III) Mimochrome VI analogs. 
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Figure 27 Kinetic characterization of Fe(III) Mimochrome VI analogs: dependence of the initial 
rate (v0) versus pH . experiments were carried out in100 mM phosphate solutions in the pH range 
4.5-8, 50 % TFE(v/v). 
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Table 4 Steady state kinetic parameters for H2O2 oxidation of ABTS catalyzed by Fe(III)-
Mimochrome VI(a: Nastri et al., 2011), its analogs, MP-11 and MP-8(b: Adams and Goold, 1990) 
and natural HRP(b: Nastri et al., 2011).  
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3.2 Mimochrome VI E2L TD: structural characterization 
In order to gain more insight about the effects of the amino acid 
substitutions on the catalytic properties of the molecules here described, a 
preliminary structural characterization of the Fe(III) Mimochrome VI E2L 
TD analog was performed. This molecule was selected on the basis of its 
highest kcat, which makes it the most promising catalyst of the new 
generation of Mimochrome VI. 
3.3 Mimochrome VI E2L TD: analysis of the secondary 
structure 
The first structural feature, which was investigated through circular 
dichroism spectroscopy, was the secondary structure content and its 
dependence towards the co-solvent trifluoroethanol (TFE) (figure 28). 
 
Figure 28 Secondary structure of Fe(III) Mimochrome VI E2L TD. CD spectra of Fe(III) 
Mimochrome VI E2L TD  (7.15∙10-6 M) in phosphate buffer (10 mM, pH 6.5) at various TFE per-
centages (v/v), recorded in 1 cm path length cuvette. 
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All spectra are characterized by a negative band around 220-222 nm 
(amide  transition n-π*), a negative band between 202-207 nm (amide 
transition  π-π*) and a positive band around 190 nm (amide transition π-
π*, perpendicular coupling). These band position indicative of peptide 
chains in α-helical conformation.  
In particular, some parameters can be more clearly indicative of this type 
of conformation. These parameters, whose values in the present spectral 
characterization are summarized in table 5, are: 
 the ratio between the ellipticity of the minimum at 222 nm and the 
minimum at shorter wavelength (θratio), 
  the position of the minimum to the lowest wavelength (λmin), 
 the wavelength value at the zero point of ellipticity (λ0) 
Generally, the intensification of the mean residue molar ellipticity at 222 
nm (θ222), joined to an increase of θratio to a value close to unity, a shift 
towards 207 nm of the λmin and a shift of the λ0 value towards higher 
wavelengths, are indicative of stabilization of helical structures (Fasman, 
1996; Vuilleumier and Mutter, 1993). 
As it can be observed by the modifications of the CD spectra shapes 
(figure 28), the trend of θ222 versus TFE percentage (figure 29 and table 
5), TFE addition induces the stabilization of the α-helical structure. In 
fact, when adding the co-solvent, it can be observed: 
 the shift of the λmin from 202 nm to 207 nm;  
 the enhancement of the θ222, from -2200 to -9700 deg cm
-1dmol -1res-1; 
 the increase of the θratio from 0.36 to 0.77; 
 the shift of λ0 from 193 nm to 200 nm. 
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The presence of a isodichroic point at 202 nm suggests a transition 
between a random coil and a helical conformation induced by TFE, as 
reported in literature (Jasanoff and Fersht, 1994). It can be deduced that 
the maximum α-helical stabilization is reached at 30% TFE (v/v) and that 
at 50 % TFE (v/v) there are no more structural  transitions. 
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Figure 29 Mean residue ellipticity as function of TFE  for  Fe(III) E2L TD Mimochrome VI. 
Table 5 CD parameters for Mimochrome VI E2L TD secondary structure. 
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 θ222 ∙ 10-3 
(deg cm-1dmol -1res-1) 
-2.2 -4.3 -7.5 -8.6 -9.2 -9.6 -9.7 
θmin ∙ 10-3 
(deg cm-1dmol -1res-1) 
-6.1 -6.9 -9.9 -11.2 -12.0 -12.5 -12.6 
θratio 0.36 0.62 0.76 0.77 0.77 0.77 0.77 
λ0 (nm) 193 198 199 200 200 200 200 
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3.4 UV-vis spectroscopy of porphyrins: an overview 
UV-visible spectroscopy has been widely applied for the characterization 
of peptide-based heme-protein models, because it is one of the most 
powerful techniques for the analysis of the heme properties. Useful 
information on artificial porphyrin containing  systems can be obtained by 
comparing their spectral properties with those of natural heme-proteins, 
and vice versa.  
The porphyrins and their various metal complexes show very distinct 
spectra and UV-visible spectroscopy can be conveniently applied for 
ascertain: (i) the insertion of the metal into the porphyrin ring, (ii) the 
oxidation and spin state of the metal, (iii) the nature of the axial ligands. 
The highly conjugated p-electron system of the porphyrin ring is 
responsible for its intense color. Two  π → π* electronic transitions are 
responsible for the absorption bands, typically found in the porphyrin 
spectra (Adar, F., 1978; Buchler, J.W.,, 1979; Eaton, W.A., 1981; 
Gouterman, 1961). An intense band is detected around 400 nm, and it is 
referred to as  B  band, or  Soret  band or  γ  band; much weaker bands 
are observed in the 500-600 nm visible region (table 6). 
Table 6 Scheme of porphyrins electronic transitions. 
 Transition ε (M-1c-1) 
Soret →  ≈ 10
5  
,  →  ≈ 10
4 
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These weaker bands are referred to as Q bands or β-α bands. The α band 
corresponds to the lowest porphyrin  π  →  π* singlet transition , and 
the β and to the vibronic envelope  (Dolphin, 1979; Gouterman, 1961). 
The visible bands are very sensitive to the metal inserted into the 
porphyrin ring, and to peripheral substituent groups.  
The  and  transitions are polarized in the x, y  plane of the por-
phyrin: for a metal porphyrin, with  symmetry, the dipole transitions 
in the x and y directions are equivalent and both the  and  
transitions are doubly degenerate. Thus, the spectrum of a metal 
porphyrin usually shows two bands in the visible region. In free base 
porphyrins, two protons are linked to two opposite inner nitrogens. In 
this case, the porphyrin plane no longer possess the four fold symmetry 
and  β  and α  bands splits. In fact, the degenerate  transition is 
replaced by transitions polarized along each of the non-equivalent x and y  
axis,  and . Each transition has its vibronic envelope (  and ), 
and, as a consequence, four distinct bands characterize the spectrum of 
free base porphyrins in the visible region (Adar, F., 1978; Buchler, J.W.,, 
1979; Eaton, W.A., 1981; Gouterman, 1961). 
The positions of the Soret,  β  and  α  bands depend on the metal electron 
configuration, and the energy of the transitions varies as a consequence of 
the coupling between the metal and the porphyrin orbitals.  
The absorption spectra of metalloporphyrins are thus classified into three 
types, normal, hypso and hyper (Buchler, J.W.,, 1979).  
Normal-type spectra are observed for a majority of metalloporphyrins 
with closed shell metal ions, where the relevant porphyrin π orbitals do 
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not significantly interact with the metal orbitals. The  Soret, α and β bands 
are often found around 400 nm, 570 and 530 nm, respectively.  
Hypso-type spectra follow the normal absorption pattern, but all bands 
are blue-shifted, due to filled metal d orbital to porphyrin π* back 
donation. Metal ions that cause  hypso-type spectra are limited to those of 
d6-d9electron configuration. 
Finally, hyper-type spectra consist of more-or-less shifted α-, β-,and  Soret 
bands and one or more additional bands. They are difficult to analyze 
because the number of extra-bands varies from one metal ion to another, 
and the positions of all bands are far more dependent on the axial ligands 
than in the other types (Buchler, J.W.,, 1979). Metal ions with d1-d5 
electron configuration show these hyper type spectra. Most of them can 
be easily found in lower oxidation states within the porphyrin, causing 
normal- or hypso-type spectra. Mn(III)- and Fe(III)-porphyrins are the 
best known examples in this respect. 
The UV-visible spectra of heme-proteins show absorption patterns quite 
similar to those observed in simple metalloporphyrins. They are very 
sensitive to the oxidation and spin state of the iron, which are modulated 
by the protein environment. In addition to the Soret, β and α bands, four 
extra-bands are found in the lower energy of the visible region, and they 
are usually referred to as IV, III, II and I (Bullock and Myer, 1978). 
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3.5 UV-vis characterization of Mimochrome VI E2L TD: 
free base and metal complex 
In order to verify that the porphyrin ring was not subjected to chemical 
modification during the synthesis, and to analyze the spectroscopic 
modification of Mimochrome VI E2L TD upon Fe(III) ion insertion, the 
UV-Vis spectra of both free base and metal complex were analyzed 
(figure 30Figure 31). 
 
 
Figure 30 UV-vis spectrum of Mimochrome VI E2L TD free base. Spectrum recorded in H2O/ 
TFE 50% (v/v) at pH 6.5. Free base concentration 1.0∙10-5M. 
 
The free base spectrum in the visible region is characterized by the 
presence of four distinct bands, localized at 498 nm, 533nm, 563 nm and 
614 nm, and by a much more intense band at 397 nm (Soret band).  
The number of the bands in the visible region is in agreement with the 
four not equivalent transitions, expected on the basis of an asymmetrical 
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system, due to the presence of two protons on two nitrogen atoms in the 
porphyrin ring. 
 
Figure 31  UV-vis spectra of Fe(II) Mimochrome VI E2L TD at pH 2.0 (red line) and 6.5 (blue 
line). Spectra are recorded in H2O/ TFE 50% (v/v). Fe(II) Mimochrome VI E2L TD 1.2∙10-5M. 
 
Analysis of the Fe(III)-complex spectrum confirmed the successful 
insertion of the iron. At pH 2.0, the system exhibits a hypso-type 
spectrum in which all bands underwent a blue shift (figure 31). In 
particular, the Soret band shifted from 397 nm to 388 nm, while the 
bands in the visible region are positioned at 494 nm, with a shoulder at 
526 nm, and 610 nm. This spectrum is consistent with a hexa-coordinated 
high-spin compound: the histidine residue, at this pH, is protonated  and 
the iron is coordinated by two weak axial ligands (two water molecules). 
The position and intensity of the bands provide useful information on  
the metal coordination state. Increasing the pH from 2.0 to 6.5 causes a 
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decrease in the intensity of the Soret band, together with a slight red shift. 
In fact, in water at pH 6.6, the maximum of the Soret bands hifts from 
389 nm to 391 nm, while the bands in the visible region move from 494 
nm to 486 nm (β band) and from 610 nm to 601 nm (CT 
band).Furthermore, the band near 350 nm (N band region) broadens and 
the  its relative intensity to the Soret band changes. These spectral 
modifications are consistent with changes in the ferric ion axial 
coordination from  H2O/H2O to His/H2O, in the high spin state (Nastri 
et al., 2011). 
This spectral behavior was observed in simple porphyrin systems, such as 
deuterohemin–histidine (Fe(III)-DP-His) (Casella et al., 1996),  and 
deuterohemin-peptide-histidine adduct (Fe(III)-DP-P11-His) (Casella et 
al., 1991), as well as in some natural heme-proteins, with reconstituted 
Fe(III) deuteroporphyrin, as myoglobin (Rossi-Fanelli and Antonini, 
1957) and hemoglobin (Antonini et al., 1964), which present an imidazole 
and a water molecule as axial ligands (table 7). 
Table 7 Spectroscopic parameters of  Fe (III) Mimochrome VI  E2L TD and others iron 
deuteroporphyrin complexes. 
Compound Solvent 
Soret 
(nm) 
β 
(nm) 
CT 
(nm) 
FeIIIMimo VI E2L TD H2O/TFE pH2 388 494 612 
FeIIIMimo VI E2L TD H2O/TFE pH6.5 389 490 612 
FeIIIMimo VI H2O pH 2.0 389 495 611 
FeIIIMimo VI Buffer/TFE pH 6.5 391 490 602 
Ac-MP8 pH 7 395 494 622 
Ac-MP8 pH1.5 394 494 620 
FeIII-DP-His H2O/ CH3OH 390 492 616 
FeIII-DP-P11-His CH3OH 390 490 590 
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3.6 UV-vis characterization of Mimochrome VI E2L TD: 
study of the coordination properties 
In order to study in more details the coordination properties of the 
complex, a UV/Vis pH  titration of Fe (III) Mimochrome VI E2L TD 
was performed in the pH range 2.0–10.0 in aqueous solutions and in the 
presence of 50% TFE (v/v) (figure 32). The progressive increase of the 
pH, causes some modifications of the spectrum, which suggest ligand 
exchange, in analogy of what it was observed for Fe(III) Mimochrome VI 
(Nastri et al., 2011). Two transitions, with midpoints at pH 3.4 and 6.3, 
were observed (figure 33). At pH 2.0, the Fe (III) Mimochrome VI E2L 
TD spectrum is typical of a predominantly high spin ferric porphyrin 
(S=5/2), with the Soret band at 387 nm, the Q bands at 494, 525 nm, and 
then CT (charge-transfer) band at 610 nm. In the range of pH from 2.0 to 
5.5, in correspondence of the first transition, the decrease in intensity of 
the Soret and CT bands, together with a slight red shift of the Soret band, 
are consistent with changes in the ferric ion axial coordination from 
H2O/H2O to His/H2O, in the high spin state (Kennedy et al., 2001; 
Nastri et al., 2011). This behavior was in agreement with the parent 
molecule Fe(III)Mimochrome VI.  
Increasing the pH to about 7.0 causes a further decrease of the Soret band 
intensity, with a concomitant modification of the bands in the visible 
region. In fact, Q bands are detected as two main bands at 488 and 605 
nm, with two shoulders at 520 and 568 nm.  
This spectral changes can be attributed to a second variation of ligand 
field, which can be related to the deprotonation of an aspartic acid on the 
proximal site of the porphyrin (D1 on the tetradecapeptide chain). 
However, preliminary experiments of pH titration monitored thorough 
DEVELOPING NEW CATALYTIC PEPTIDE-
BASED HEME MODELS 
 
  -73- 
 
CHAPTER III 
CD spectroscopy, in the far UV region (secondary structure) and in the 
visible region (Soret band), let us to hypothesize a phenomenon of pH-
dependent oligomerization (data not shown). To gain structural insights of 
the species involved in the heme coordination at pH 6.5, corresponding to 
the active form of the molecule, further characterization by Resonance 
Raman spectroscopy, DOSY NMR and Magnetic circular dichroism are 
required and in progress. 
 
 
Figure 32 UV/vis spectra of Fe(III) Mimochrome VI (7.21x10-6 M) at various pH (2.0–10.0). The 
spectroscopic titration was performed using TFA and NaOH (at concentrations in the range 0.1–
1m), in a 1.0 cm path length cuvette. Arrows indicate the intensity modification of the Soret and Q 
bands observed by increasing the pH.   
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Figure 33 Absorption variation of the Soret band as function of pH. Data points were fitted with 
a 2 equilibrium model, which describes a first transition at pH 3.4 and a second one at pH 6.3. 
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Discussion 
All the catalytic data demonstrate that all the analogs display a good 
peroxidase-like activity.  
Table 4 reports the comparison of the catalytic parameters for all 
Mimochome VI analogs, HRP and peptide-based peroxidase models (MP-
8 an MP-11). 
The data obtained from the functional characterization of Mimochrome 
VI analogs evidenced the role of each substituted amino acid on catalysis. 
Based on the kcat values, it can be concluded that modifications in the 
decapeptide chain worsened the catalytic properties of the parent 
molecule. In fact, except the increase of the apparent affinity towards 
H2O2 displayed by the R
10L D analog, all the functional properties are 
lower for these molecules respect to Mimochrome VI.  
On the contrary, tetradecapeptide modifications have produced two 
analogs, whose catalytic efficiency is four times higher than Mimochrome 
VI, and even higher than HRP.  
The first aspect that has to be highlighted is the site-specific effect of the 
substitution. This suggests that the simple charge modifications, due to 
the E-L or R-L substitution, is not the main responsible of the catalytic 
efficiency modification, because the effects are quite different if the 
modification is in the distal or the proximal side of the deuteroheme (i.e. 
in the decapeptide or in the tetradecapeptide). 
A first hypothesis, to explain this trend can be proposed by analyzing the 
amino acid composition of the protein chains in proximity of the heme, in 
natural peroxidases. In this regard, the structures of the horseradish 
DEVELOPING NEW CATALYTIC PEPTIDE-
BASED HEME MODELS 
 
  -76- 
 
CHAPTER III 
peroxidase from A. rusticana (HRP) (Rodriguez-Lopez et al., 1996; Veitch, 
2004) and the chloroperoxidase from C. fumago (CPO) (Sundaramoorthy 
et al., 1995) were considered (figure 34). 
 
 
 
Figure 34 Crystal structure of the HRP (PDB entry ID: 1H5A) and CPO (PDB entry ID: 2CPO). 
Inset: the heme environment with the function-involved amino acids. 
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The role of the R38 in the catalytic cycle 
was widely studied, since the elucidation 
of HRP catalytic mecha-nism (Poulos 
and Kraut, 1980). Through the 
combined structural and functional 
characterization of HRP and R38 
mutants of HRP, it emerged that this 
important distal residue is involved in 
charge stabilization of a precursor 
enzyme-substrate complex, with rele-
vant effects on the trigger of the cycle 
(figure 35). In fact, R38 interacts with compound I and II, via hydrogen 
bonds, and it stabilizes the OH- group, deriving from the O-O cleavage 
occurring at compound I forma-tion, via electrostatic interactions 
(Rodriguez-Lopez et al., 1996). 
Concerning the CPO, its crystal structure reveals that the heme pocket in 
is typically polar, with an acid-base catalytic group which is not a histidine, 
as found in HRP (His42) and other peroxidases. In fact, the side chain of 
Glu183 extends from the distal helix F and is positioned directly adjacent to 
the peroxide-binding site. The catalytic role of E183 is probably similar to 
that of the distal histidine in peroxidases (e.g. H42 in HRP): the carboxylate 
accepts a proton from the incoming peroxide and donates a proton to the 
leaving hydroxyl group, thus facilitating the heterolithic cleavage of O-O 
bonds and the consequent formation of the compound I (figure 35) 
(Sundaramoorthy et al., 1995). 
Hence, it emerges that a Glu or a Arg residue in the distal site of the heme 
can be actively involved in the catalytic cycle, thus significantly 
determining the functional properties of the enzyme.  
Figure 35 Peroxidase catalytic cycle and 
compound I and II formation. 
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On the basis of these considerations, it can be 
hypothesized that, in E2L and R10L TD analogs, 
breaking inter-chain ion pair could leave free 
the corresponding R10or E2on the distal side of 
the heme. These residues could undergo to a 
conformational change, thus pointing directly 
to the heme and participating to the reaction 
mechanism, similarly to what observed for the 
natural peroxidase above described (figure 36). 
 
Based on the preliminary structural characterization of E2L analog, other 
considerations can be done. The secondary structure content (figure 28, 
figure 29) and the pH-dependence of the catalytic activity (figure 27) 
seem to be not so far different from Mimochrome VI. However, the UV-
vis spectroscopy has revealed a difference in the pH titration for the study 
of the chemical environment of the heme and its coordination properties 
(figure 32). In fact, in Mimochrome VI two transitions were found at pH 
3.4 and 7.4, respectively. The first transition was related to the His6 
deprotonation and its consequent coordination to the heme, while the 
second one was related the coordination of -OH- groups, due to the pH 
increase (Nastri et al., 2011). Concerning the E2L TD analog, while the 
coordination of the H6 seems to occur in the same conditions as in 
Mimochrome VI, a second transition occurs at pH 6.3. This is not really 
explainable with the OH- coordination to the heme, because this 
hypothesis would be disproven by the maximum of the catalytic activity 
revealed at that pH value. It is possible that some other amino acids can 
participate to the coordination properties of the molecule (e.g. D1 on the 
Figure 36 Proposed effect of 
the E2L TD substitution. 
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tetradecapeptide chain), thus influencing the structure of this new 
molecule.  
Another possibility is that the amino acid substitution has induced the 
formation of a dimer, or more generally an oligomer, which could be 
stabilized at pH 6. Thus, these evidences could be used as starting point to 
rationalize the structure/function differences between E2L TD analog and 
Mimochrome VI. Further structural characterization by resonance raman 
spectroscopy, magnetic circular dichroism, NMR and DOSY NMR are in 
progress in order to gain more information about the structural properties 
of this new minienzyme, which can be related to its notable catalytic 
efficiency. 
It should be highlighted that  Fe (III) Mimochrome VI  E2 TD is, to the 
best of our knowledge, the first artificial heme-enzyme, whose catalytic 
performance approaches that of HRP. The kcat value observed for this 
minienzyme is only 7.9 -fold lower than HRP, in the experimental 
conditions for maximal activity for each enzyme, whereas the kcat value of 
Fe (III) Mimochrome VI E2L TD is about 15 -fold higher than HRP at 
neutral pH.  
Moreover, Fe (III) Mimochrome VI  E2L TD  shows a significant 
improvement in the activation of H2O2, respect to Fe(III)-Mimochrome 
VI. In fact, the catalytic efficiency of the new developed heme-enzyme  
for the reducing substrate is about 3- and 4-fold higher than HRP and 
Fe(III)-Mimochrome VI, respectively. 
The catalytic activity of Fe (III) Mimochrome VI E2L TD, which is 
comparable to those of complex proteins, demonstrated that its 
miniaturized structure holds essential elements for tuning the iron-
porphyrin peroxidase activity. 
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4. Spectroelectrochemistry: combined techniques for the 
characterization of heme-proteins 
Mimochrome VI represents a very interesting heme-protein model, whose 
electrochemical features can be exploited in order to develop new bio-
inspired- analytical tools, such as electrochemical biosensors.  
The most diffused approach, for the set up of this kind of biosensors, is to 
immobilize a redox active molecule (such as heme-proteins and/or heme-
enzymes) on the surface of an electrode. This configuration is commonly 
called in electrochemistry protein film voltammetry (PFV). When the 
immobilized molecule is an enzyme, and the applied electrode potential is 
appropriate, electrons flow between the substrate and the electrode, via the 
active site of the enzyme. The magnitude of the detected current is simply 
proportional to the turnover rate of the enzymatic reaction. Ideally, 
interfacial electron transfer (ET) may be fast and the electrode may be 
rotated at high speed to avoid mass transport control, so that the current 
response directly reports on the intrinsic properties of the enzyme.  
Three fundamental reasons make PFV potentially much more informative 
than other methods, for assaying enzyme properties. First, the potential of 
the electrode can be continuously swept, to provide whichever driving force 
is required to elicit catalysis. Hence, each data point along the 
voltammogram can be thought of as an “initial rate” in solution assay, that 
can be carried out under precise control of the redox conditions (Cornish-
Bowden, 2004). Second, experiments can be carried out over a wide range 
of accessible timescales, in order to study both transient and steady-state 
processes. Third, the change in catalytic turnover rate instantly translates 
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into a variation of current. It is essential, in this respect that the current 
response is not convoluted and obscured by co-substrate diffusion and 
intermolecular electron transfers (as is the case for mediated electro-
chemistry). Together with the precise redox control, this excellent temporal 
resolution of the activity assay allows to precisely characterize how activity 
quickly evolves with time, following an instant change in experimental 
conditions. This was found to be particularly useful for studying the kinetics 
of inhibition, activation, or inactivation of several enzymes. These processes 
involve redox and redox-coupled transformations, that occur on short time 
scales and thus cannot be resolved in normal activity assays (Léger and 
Bertrand, 2008).  
However, PFV also has some drawbacks. First, the limited electroactive 
coverage of redox-active proteins often corresponds to poorly detectable 
electrochemical signals from direct oxidation or reduction. Second, the 
native structure of proteins often undergoes somewhat alterations, thus 
making necessary the use of other techniques, which provide information 
about biomolecules in the native state. Third, direct electron transfer does 
not give any information on the chemical nature of the redox processes, 
since this technique detects electron flux, without giving accurate 
information about the chemical species involved. Fourth and final, the 
measured current may be affected by double layer capacitance and/or by 
current associated to contaminant species (e.g. in the electrolyte or adsorbed 
on the electrode surface), which could not be always recognized by 
conventional electrochemical measurements. 
In this context, the afore-mentioned limitations may be overcome by 
coupling spectroscopy techniques to PFV (Ash and Vincent, 2012). The 
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goal of this kind of approach is to detect not only the current signal, but 
also the optical spectrum, upon electrode polarization.  
Different spectroscopic techniques were combined with direct electro-
chemistry, to study immobilized redox-proteins, such as UV-visible (Dong 
et al., 1995; Whitehouse et al., 2009; Wu et al., 2011), fluorescence (Bernad 
et al., 2007; Krzemiński et al., 2011; Salverda et al., 2010), infrared (Iwaki et 
al., 2005; Lacey et al., 2008; Marshall et al., 2006), magnetic circular 
dichroism (Marritt et al., 2006) and resonance raman spectroscopy 
(Bernad et al., 2007; Hildebrandt and Stockburger, 1989; Khoa Ly et al., 
2011; Kranich et al., 2009). 
Typically, spectroscopic techniques are more sensitive than electro-chemical 
ones and they are not affected by the presence of capacitive current, which 
usually leads less accurate data by voltammetry (Astuti et al., 2004). 
Over the years, spectroelectrochemistry was established as a technique of 
choice to study immobilized enzymes, by monitoring redox-related current 
signals and spectral changes. In particular, it was found that cross-
correlations between electrochemical and optical data can be very useful in 
elucidating some thermodynamic and kinetic properties (Renault et al., 
2011). The information, that can be achieved by the two techniques 
synchronized each other, are complementary. For example, a more reliable 
estimation of the surface coverage of the electrodes can be obtained 
through the comparison of spectroscopic and electrochemical data. In fact, 
one of the main limits of PFV is the difficult determination of kinetic 
properties, such as kcat. This parameter, that is so easily measured in solution 
assays,  cannot always be determined in PFV, because the exact amount of 
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adsorbed enzyme is not accurately determined or even unknown (Léger and 
Bertrand, 2008).  
For this reason, in the last years intense research activity was devoted to 
spectroelectrochemistry and time-resolved spectroelectrochemistry (Renault 
et al., 2012; Venturi, 2012).  
The availability of conductive and relatively transparent materials is 
necessary for this kind of approach. Great interest is focused on the optical 
and electrochemical characteristics of metal oxides. Durrant and coworkers 
gave a great contribution to the application of metal oxides (nanocristalline 
mesoporous SnO2 and TiO2 electrodes) for the successful characterization 
of natural redox proteins (eg. flavodoxin, peroxidases, cytochromes, etc.) 
(Astuti et al., 2009, 2011; Green et al., 2005, 2005; Kemp et al., 2009; 
Panicco et al., 2008). However, the semiconductive nature of SnO2 and 
TiO2, limits the potential windows that can be explored, and restricts their 
use to address the kinetics of fast electron-transfer reactions (Renault et al., 
2011). Moreover, the randomly sintered nanoparticles of SnO2 and TiO2 
that are usually used for these electrode functionalization generally lead to 
poor accessibility of biomolecules within the porous film (Renault et al., 
2011). 
 Balland, Limoges and coworkers used conductive mesoporous nano-
structured films of tin-doped indium oxide (ITO) as practical platform for 
the immobilization of several heme-proteins (e.g. cytochrome c, neuro-
globin and microperoxidase-11) an their spectroelectrochemical chara-
cterization (Renault et al., 2012; Schaming et al., 2012). They coupled  cyclic 
voltammetry to time-resolved UV-vis spectroscopy in order to characterize 
the heterogeneous ET of the immobilized metalloproteins on ITO 
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electrodes, and they even succeeded in determining the catalytic mechanism 
of O2 reduction mediated by microperoxidase -11 (Renault et al., 2012; 
Schaming et al., 2012). 
 
4.1 Spectroelectrochemical characterization of 
Mimochrome VI: towards biosensor development 
The advantages of using small peptide-based heme-protein models, as 
electroactive molecules in electrochemical analytical systems, are dual.  
On one hand, the molecular weight and the relative molecular size of these 
artificial molecules are much lower than natural heme-proteins. This makes 
possible to significantly increase the surface coverage of the electrodes and, 
hence, to considerably increase the number of molecules per electroactive 
unit area.  
On the other hand, the absence of the high dimensions protein matrix 
allows to avoid the interferences with the electronic pathways during the 
redox processes, which usually make the direct electron transfers (DET) 
inefficient or even absent. High surface coverage and efficient DETs 
together have the effect of notably increasing the intensity of the 
electrochemical signal, thus considerably bettering the sensitivity and the 
reliability of these type of analytical measurements. 
Moreover, the discrete spectroscopic features of porphyrins and their metal 
complexes (e.g. the high molar extinction coefficient and the discrete 
spectral variations related  to the oxidation, spin and coordination states of 
the metal ion) make these molecules, and hence heme proteins and heme 
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protein models, very interesting object for the characterization of the redox 
processes by spectroscopic techniques. 
The spectroelectrochemical characterization of Fe(III) Mimochrome VI 
immobilized on ITO electrodes was realized in collaboration with Prof. 
Véronique Balland and Prof. Benoit Limoges, at the Laboratories d’électrochimie 
moléculaire (LEM) of Paris. The aim of this part of the research activity was 
focused on the thermodynamic and kinetic characterization of the 
heterogeneous electron transfer and the study of the catalytic reduction of 
dioxygen. In addition to fundamental studies the development of 
Mimochrome functionalized highly transparent and porous 3D electrodes 
will allow to explore their potentialities in the development of high density 
biosensors (figure 37). 
 
 
Figure 37 Mimochrome VI immobilized on ITO electrode and catalytic reduction of O2. 
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4.2 Mesoporous nanocrystalline 3D ITO electrodes 
Tin-doped indium oxide (ITO) is one of the most interesting materials for 
applications in spectroelectrochemistry, since it combines the optical 
transparence and a typically metal-like conductivity, and it can be easily 
deposited as a thin film on solid supports, for practical applications. 
The use of this type of metal oxide has two important advantages respect to 
semiconductive metal oxides (e.g. SnO2 and TiO2): 
 it is possible to explore wider potential windows; 
 the ET are faster, thus providing the possibility  of developing time-
resolved spectroelectrochemical measurements. 
Two different strategies can be used to prepare thin conductive films of 
doped metal oxide, with controlled porosity and transparency. One is based 
on hybrid organic-inorganic sol-gel process, which allows to obtain thin 
films of doped metal oxides with a 3-D mesoporosity (Fattakhova-Rohlfing 
et al., 2006; Wang et al., 2009) (figure 38). This method allows to obtain 
well-organized nonporous structures, but with restricted film thickness as 
well as limited porosity (~ 15-20 nm) (Renault et al., 2011). 
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Figure 38 Scanning transmission electron microscopy images in high-angle annular dark-field 
contrast (STEM-HAADF) of the film in a direction a) perpendicular and b) parallel to the substrate 
plane show ITO by bright and porosity by dark contrast. c) HRTEM image of a 20 nm side length 
section of the mesostructure (Fattakhova-Rohlfing et al., 2006). 
A second approach is represented by vacuum-based glancing angle 
deposition (GLAD) (Krause et al., 2010; Robbie, 1998). This technique 
consists in a single step physical vapor deposition of a metal oxides on solid 
supports (figure 39). Under vacuum atmosphere, the ITO solid block is 
sublimed by electron bombardment and the so-generated vapor flux is 
directed on a rotating  solid support. Polycrystalline columnar structures are 
then generated and vertically elongated, thereby forming a porous oxide 
film. The most important advantage of this technique, respect to the 
previous one, is the possibility of controlling the morphology of the 
deposited films, which can be modulated by regulating: 
 the deposition angle (α); 
 the rate of the incident flux; 
 the rotation speed of the support. 
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Figure 39 GLAD technique for ITO deposition on solid supports. 
The regulation of the morphology of the deposited film is realized in order 
to adjust the thickness, the surface area, the shape and the porosity of the 
ITO- nanosized columnar structures. In figure 40 the top-view and the 
cross-sectional SEM images of GLAD ITO films are shown, having four 
film thickness (ranging from 0.25 to 2μm). As it can be observed in these 
images, as the film thickness is increased, the density of the columns 
decreases (from ~70 to 8 columns per μm2), while their diameter increases 
(~90 to 270 nm). As consequence, the void spacing between the columns 
increases (~40 to 90 nm). Clearly, even the optical transparency  and the 
conductivity are affected by the film thickness: they decrease and increase, 
respectively, as the film thickness is raised.  
One very interesting aspect of GLAD ITO films is the notable surface are 
enhancement, due to this columnar architecture. This allows to immobilize 
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biomolecules as a monolayer, directly communicating with the electrode, 
thus significantly bettering the DET of these systems. 
Clearly, for suitable spectroelectrochemical characterization of adsorbed 
molecules, it is quite important to select an appropriate GLAD ITO film 
thickness, which should be a good compromise between transparency and 
surface enhancement. 
 
Figure 40 Scanning electron micrograph (SEM) images of different GLAD ITO films prepared with 
a deposition angle of 80° for different film thickness (side- and top-views) (Renault et al., 2012). 
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4.3 3D ITO electrode selection and characterization  
The first step for Mimochrome VI spectroelectrochemical character-ization 
was the selection of the most suitable ITO electrode and the 
characterization of its optical and electrochemical properties. 
In analogy to the system developed for microperoxidase 11, 1 μm film 
thickness of ITO electrode was selected, since for this small peptide-heme 
adduct, which is very similar to Mimochrome VI molecular structure, this 
represented a good compromise between optical and electrochemical 
properties (Renault et al., 2012). In order to determine its optical 
transparency, the absorbance spectrum of the nude ITO electrode was 
recorded (figure 41). In the ultraviolet region of the spectrum (λ ≤ 350nm) 
an intense band is detected, which  corresponds to the electron transition 
from the valence band to the conductive band of the ITO. Nevertheless in 
the visible region, ITO are mostly transparent, due to the large band-gap 
value of this materials, exhibiting only small interference fringes, due to the 
optical scattering caused by the ITO columnar structures. 
When increasing the film thickness, the optical transparency of the ITO, in 
both ultraviolet and infrared regions, considerably increases, thus affecting 
the spectroscopic detection of the adsorbed molecules (Renault et al., 2012). 
Considering that the Soret band position of Fe(III) Mimochrome VI is 
detected at 389 nm (pH 6.5), this film thickness was confirmed to be a good 
compromise between conductivity and transparency. 
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The capacitance of the examined electrodes was determined  in oxidative 
potential window (from 0.4 V to 0.0 V) at different scan rates (0.01-2V/s). 
The current intensities were normalized for the geometric surface area (0.24 
cm2) and plotted versus the scan rate. The slope of the determined straight 
line is the capacitance of the electrode. The value of 546 μF/cm2 agrees 
with that typically determined for this film thickness (Renault et al., 2012). 
 
Figure 41 UV-vis absorbance spectrum of  GLAD ITO (1 μm film thickness). 
SPECTROELECTROCHEMISTRY OF 
MIMOCHROME VI 
 
-92- 
  
CHAPTER IV 
 
Figure 42 Current density (mA/cm2) as a function of scan rate (V/s). 
 
4.4 Spectroscopic characterization of Mimochrome VI 
adsorbed on ITO electrode 
Enzymes are often immobilized on surfaces such as particles, films or 
coated on electrode surfaces for a wide range of applications, from 
biosensors to biocatalysts. However, the utility of an enzyme in a given 
process is guided by its structural properties, such as the conformational 
stability and the coordination state of metal cofactors. Clearly, the 
immobilization on a support can add, to the original molecular system, 
numerous potentially disturbing elements, which can depend on the surface 
nature of the support material, cross linkers, stabilizers, ionic strength, etc 
(Khan et al., 2011). Usually, the stability of the surface bound enzymes is 
evaluated from their catalytic activity alone, as it is technically not possible 
to obtain more structural information. The availability of a transparent 
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support (ITO electrode) makes possible to compare some spectroscopic 
characteristics of the adsorbed molecule with those found in solutions, thus 
allowing to conclude if the structure of the molecule is affected or not by 
the immobilization process. 
For this purpose the UV-vis absorption spectrum of Fe(III) Mimochrome 
VI in solution was compared to the spectrum of the molecule immobilized 
on ITO electrode (figure 43). It is evident that the two spectra are quite 
similar, showing the same λMAX (389 nm) and the same amplitude of the 
absorption peak of the Soret band. This result suggests that no 
modifications of the deuteroheme coordination geometry and spin state 
occurs upon adsorption on ITO electrode. 
 
Figure 43 Comparison of UV-vis absorption spectra of Mimochrome VI in solution (red) and 
adsorbed on ITO electrode (blue). 
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In order to confirm this hypothesis, the same approach was applied for  the 
comparison of the resonance raman spectra (figure 44). This spectroscopic 
technique allows to obtain information on the vibrational properties of the 
molecules, and it is powerful in the study of bioinorganic complexes and 
heme proteins. It is reported that the 1300-1700 cm-1 region in the 
resonance raman (RR) spectra of hemes are characterized by the presence 
of bands, which are recognized as core-size and spin- state markers (Weiss 
et al., 2006). The dependence of the position of these marker bands reflects 
changes in methine- bridge force constants, which are due to the expansion 
or the contraction of porphyrin, and can be correlated to the porphyrin 
coordination and spin states. This conclusion derives from the observation 
that in six-coordinated complexes, iron lies close to the heme mean plane, 
whereas in five-coordinate complexes iron is displaced from the heme mean 
plane to the fifth ligand (Weiss et al., 2006). In the first case, expansion of 
the heme occurs, while in the second case heme is contracted, as a 
consequence of iron displacement. These skeletal mode frequencies well 
define the coordination and spin states of the examined compounds and 
they can be detected by resonance raman spectroscopy. 
Even in the case of RR spectra, it is possible to observe that the position of 
the marker band υ2, υ3, υ4 and υ10, of the molecule in solution and 
immobilized on ITO electrode, are practically the same.  This confirms that 
the coordination and the spin state of the molecule are not modified upon 
the adsorption on ITO electrodes. 
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Figure 44 Comparison of resonance raman spectra of Mimochrome VI in solution (50 μM in 10 mM 
MES buffer pH 6.5) -orange line - and adsorbed on ITO electrode -red line- . As reference the 
protein-free ITO spectra is also reported -blue line (λECC= 405 nm). 
 
The last spectroscopic comparison between Mimochrome VI in solution 
and adsorbed on ITO was focused on the Fe(III)/Fe(II) forms.  
The spectroelectrochemical redox titration, which will be discussed in more 
details after, was performed in a home-made spectroelectrochemical cell 
(filled with 90 mM MES buffer, 10 mM KPF6 solution at pH 6.5) by 
applying reducing potential. The spectrum of the fully reduced was 
subtracted of the spectrum of the ferric Mimochrome VI-ITO, to obtain 
the difference spectra reported in figure 45. Even in this case, the ferrous 
and ferric λMAX, as well as their relative ratio, are un-modified upon 
adsorption. 
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In conclusion, the overall results demonstrate that the coordination, the 
spin state and, more generally, the spectroscopic characteristics of the 
molecule are not affected by the interaction with the metal oxide film. 
Therefore, Mimochrome VI represents an interesting example of synthetic 
and peptide-based heme-protein model, whose redox properties can be 
conveniently studied by spectroelectrochemistry. 
 
Figure 45 Difference spectra (oxidized minus reduced) in solution (red line) and adsorbed on ITO 
electrode (blue line). Experiments were conducted in 90 mM MES buffer, 10 mM KPF6, pH 6.5. 
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4.5 Kinetic of adsorption and desorption of Mimochrome 
VI on ITO electrode 
Generally, molecules can be immobilized on metal oxides surfaces either by 
physisorption and chemisorption modes. These materials are rich in 
hydroxyl groups, thus conferring an acid-base behavior to the film, which is 
expected to be negatively charged at neutral pH. Hence, physisorption 
process is usually achieved by the formation of hydrogen bandings, van der 
Waals forces, electrostatic interactions and by physical entrapment within 
the film porous. Moreover, the metal component of the matrix let possible 
the establishment of coordination bonds typical of chemisorption (e.g. 
unidentate, bidentate chelating and bidentate bridging). The amino acid 
composition of Mimochrome VI peptides is characterized by the presence 
of both positively and negatively charged residues which are supposed to 
mediate a fast and stable physisorption to the electrode. Moreover, the 
carboxylate groups of glutamate and aspartate residues could mediate 
chemisorption processes, further stabilizing the ITO-Mimochrome VI 
system.  
In order to determine the kinetic of the adsorption of Mimochrome VI, the 
ITO electrode was soaked, at room temperature, in a 50 μM Fe(III) 
Mimochrome VI solution (in 10 mM MES buffer, pH 6.5), during a deter-
mined time. The low ionic strength of this solution was required, since the 
physisorption and chemisorption processes could be hindered at higher 
ionic strength, masking charge-mediated interactions. The increment of the 
absorbance at 389 nm, in the blank-subtracted spectra, was indicative of 
Mimochrome VI adsorption on the electrode. The experimental point, 
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which were plotted versus the incubation time, showed a very fast 
adsorption process with a kads of 0.17 min
-1, reaching the maximum surface 
coverage in about 30 minutes (figure 46). 
 
Figure 46 Adsorption kinetic of Mimochrome VI on ITO electrode.  
In order to assess the stability of the system at higher ionic strength, which 
are the typical experimental conditions of electrochemical measurements, 
the kinetic of desorption was also investigated. For this purpose, the 
electrode was soaked in a 90 mM MES buffer, 10 mM KPF6 at pH 6.5. This 
time the decrease of the Soret band intensity was indicative of Mimochrome 
VI desorption from the ITO electrode. Absorbance variation at 389 nm was 
potted versus the incubation time and showed a rapid removal from the 
film of ~ 10% of Mimochrome molecules initially immobilized, with a kdes 
0.9 min-1 (figure 47). This small fraction is reasonably ascribable to a 
portion of molecules, which are not stably and directly bound to the 
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electrode, but rather immobilized on it via intermolecular interactions. 
Desorption experiment were also performed at higher ionic strength, in 
order to further analyze the stability of the system. In 150 mM MES buffer, 
100 mM KPF6 solutions the system is still stable, showing a negligible 
desorption (data not shown). Hence, the stable interaction of Mimochrome 
VI with ITO electrodes, which is supposed to be driven by the peptides 
amino acid composition, was confirmed by these results. 
 
Figure 47 Desorption kinetic of Mimochrome VI on ITO electrode. Experimental points are fitted 
with a double exponential equation. 
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4.5  Estimation of the surface coverage 
The surface coverage of the ITO electrode with Mimochrome VI was 
determined by combining both spectroscopic and electrochemical data. On 
the basis of the spectroscopic characterization of Mimochrome VI adsorbed 
on ITO electrode, it is possible to assume that the extinction coefficient of 
the adsorbed mini enzyme is the same as determined in solution (pH 6.5 
ε389=63 000 M
-1cm-1 (Nastri et al., 2011)).  
The surface coverage Γ, which is determined by the absolute absorbance (λ 
= 389 nm) divided by this ε value, and considering 1 μm film thickness, is 
estimated to be 2-3 ∙10-9 mol/cm2. This value was compared to the one 
obtained by integrating the faradic peak current in the corresponding 
voltammograms, subtracted of the blank (nude ITO electrode).  
The electrochemically-determined Γ was lower than the previously 
determined (~7 ∙10-10 mol/cm2). This discrepancy can be explained on the 
basis of the important optical contribution of the ITO electrode in the UV 
region, which could cause a incorrect blank subtraction in the spectroscopic 
data and an over estimation of the Γ value. This inconvenient was already 
encountered by Balland and co-workers in previous works on other heme-
proteins adsorbed on ITO (Renault et al., 2011, 2012; Schaming et al., 
2012).  
Time-resolved spectroelectrochemistry allows to overcome this problem. It 
is possible to monitor the absorbance variation at a specific wavelength, as a 
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function of time, during the redox cycle, occurring at the polarization of the 
electrode.  
The 421 nm wavelength, indicative of the Fe(II) formation in the film at 
reducing potential, was selected for this purpose.  A stable absorbance 
variation of 40 mOD was detected at different scan rates, suggesting that 
the redox process is reversible and that the Γ does not change over the time 
(e.g. for desorption of Mimochrome VI from the film). This ΔAbs value 
can be normalized for the Δε, determined in solution to estimate the surface 
coverage of the electrode. The Γ value obtained by this approach was the 
same as determined by electrochemistry.  
table 8 compares the Γ values of Mimochrome VI and microperoxidase-11, 
obtained by using the same electrode film thickness (1μm) (Renault et al., 
2012). The lower Γ value obtained for Mimochrome VI can be explained 
considering  the slight difference in molecular weights. Moreover, MP-11 is 
adsorbed as an aggregate and hence it is possible that its molecular diameter 
is smaller respect to Mimochrome VI, thus explaining the higher surface 
coverage. However, the columnar architecture of ITO films alllows to 
adsorb a high number of Mimochrome VI molecules as a monolayer, thus 
allowing the realization of a complete thermodynamic and kinetic 
characterization of the system. 
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Table 8 Saturating surface concentration obtained for Mimochrome VI and mp-11 adsorbed on ITO 
electrode (1μm). 
 MimochromeVI MP-11 
Molecular weight 3.5 KDa 1.86  KDa 
KADS 0.17 min
-1 0.18 min-1 
ГSAT ~ 7 ∙ 10
-10 mol/cm2 ~ 1 ∙ 10-9 mol/cm2 
 
 
4.6 Thermodynamics of Mimochrome VI-ITO electrode ET 
The thermodynamic characterization of the Mimochrome VI-ITO system 
was carried out in order to determine the value of the apparent standard 
potential E°’ and to verify if the Fe(III)/Fe(II) redox interconversion is an 
equilibrium process, and well described by the Nernst model.  
Redox titration of Mimochrome VI was perfomed in a spectroelectro-
chemical cell, as described in 4.5 paragraph.  Redox process was observed to 
be fully reversible, with well resolved isosbestic points at  403, 450 and 513 
nm in the difference absorbance spectra (figure 48). 
The resulting titration curve was adjusted to the Nernst equation and in the 
best fit a standard potential E°’=-0.319 vs. Ag/AgCl and a number of  
transferred electrons n=0.69. The value of the observed E°’ is just slightly 
modified respect to the value measured for the same molecule in solution 
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and immobilized on a non polar self-assembled monolayer (SAM)-coated 
gold electrode (Ranieri et al., 2010). 
The n value is lower than 1, which will be expected for one-electron 
Fe(III)/Fe(II) couple. This n value can be attributed to the distribution of 
Mimochrome VI in various orientations on the surface and in 
heterogeneous microenvironment, as previously reported (Renault et al., 
2012). In order to confirm this hypothesis, the redox titration-relative 
experimental points were fitted with Nernst equation, assuming a square 
distribution of potentials and n=1. The best fit gave  E°’ av=-0.319 V and a 
ΔE of 0.007 V (figure 49). The apparent standard potential is the same as 
determined with classical nernstian model, and the discrepancy in the number 
of electrons involved in the redox process is therefore translated in standard 
potential dispersion (ΔE). 
 
Figure 48 Reductive titration f Mimochrome VI adsorbed on ITO electrode: difference spectra 
recorded at -0.5 V (black), -0.45 V (red), -0.4 V (blue), -0.35 V (green), -0.3 V (pink), -0.25 (brown), -
0.2 V( dark blue). Experiments were carried out in 10 mM MES buffer, 10 mM KPF6, pH 6.5 in 
Argon saturated atmosphere and at 25 °C. 
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Figure 49 Fraction of reduced Mimochrome VI, determined from the 421 nm absorbance during 
reducing titration. Nernst fitting using n= 0.69 and E°’=-0.319 V; blue line: fit based on a square 
distribution of E°’ and n=1. 
4.7 Cyclic Voltammetry and Voltabsorptometry: study of the 
heterogeneous electron transfer 
The Mimochrome VI-ITO electrode was studied in cyclic voltammetry by 
monitoring the absorbance changes at the 421 nm (λMAX of ferrous Soret 
band). Experiments were performed at various scan rates, ranging from 
0.010 to 10 Vs−1, and within the potential window corresponding to the 
reduction of Fe(III) into Fe(II). Satisfactory absorbance variation signal-to-
noise ratios could be reached using integration times as low as 10 milli 
seconds.  
Cyclic voltabsorptograms (CVAs) are diagrams in which the Fe(II) fraction, 
derived from the absorbance variation at 421 nm,  is plotted versus the 
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potential (E),. Typical CVAs were obtained at different scan rate and they 
are reported in figure 50.  
 
Figure 50 Cyclic voltabsorptograms obtained in the 0.01V/s-2 V/s scan rate range. 
The derivative cyclic voltabsorptograms (DCVAs) obtained after time 
derivation of CVAs are equivalent to cyclic voltammograms (CVs), when 
both are expressed in ﬂux density ϕ according to the following equation: 
        Equation 3 
where : 
 Aλ is the absorbance at the wavelength λ,  
 Δελ is the diﬀerence in the extinction coeﬃcients between the reduced 
and oxidized species, expressed in mol−1 cm2 ;  
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 n is the theoretical number of electrons involved in the redox reaction: 
n = 1 for the Fe(III)/Fe(II) redox couple; 
 F is the Faraday constant (96 500 C mol−1),   
 S is the geometric electrode surface area (0.24 cm2). 
The blank subtracted CVs and the DCVAs in the 0.01-2 V/s scan rate 
range are reported in figure 51.  
Through the analysis of CVAs, it appears that at low scan rates (0.01V/s), 
the system is supposed to be in equilibrium, with a well-resolved 
Fe(III)/Fe(II) transition, centered at E°’= -0.319 V and a good overlapping 
between the curves describing the reduction and oxidation processes. 
However, at higher scan rates an increasing hysteresis between the 
reduction and the oxidation processes is progressively detected. This 
indicates that the system is no more in equilibrium and that the redox 
process is under the kinetic control of the interfacial electron transfer. 
Moreover, the irreversibility of the redox process detected at higher scan 
rates is also detectable in CVs and DCVA, where the progressive (i) drift of 
the anodic and cathodic potential peaks and (ii) decrease of the potential 
peaks current intensities, are observed. 
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Figure 51 Cyclic voltammogram (left) and derived cyclic voltabsotogramm (right) in the 0.01V/s-2 
V/s scan rate range. Intensities of the reversible DCVA waves were almost identical to those 
obtained with background-subtracted CVs from their large background capacitive current. 
As expected for surface-confined electroactive centers, at low scan rates 
anodic and cathodic peak current flux densities show linear dependencies 
with the scan rate (figure 52). From linear regressions to the experimental 
data, the slope value of 5.8 V −1, for the reduction process, significantly 
differs from the value of 9.9 V−1, expected for an ideal one-electron 
Nernstian redox couple at 20 °C. As a result, the full width at half-
maximum (fwhm) values of the cathodic and anodic peaks in the DCVA 
(150 mV) noticeably differ from the theoretical fwhm value of 89 mV for a 
reversible one-electron electron transfer at 20 °C.  
This deviation from an ideal Nernstian behavior can be attributed to a 
random orientation of absorbed Miimochrome VI molecules on the ITO 
surface, leading to a distribution of microenvironments around the heme 
and thus to a distribution of standard potentials (Armstrong et al., 2000). 
This is in agreement with the apparent value, napp= 0.69, that was obtained 
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by redox titration experiments, which also deviates from the theoretical 
value of n= 1 for a Fe(III)/Fe(II) redox couple. 
 
Figure 52 DCVA peak current flux densities of oxidation (black square) and reduction (red circles) 
as a function of scan rate, with corresponding linear fits with slopes of 5.8 and 5.1 V-1 
In order to study and evaluate the characteristics of the heterogeneous  
electron transfer rate, the dependence of the peak-to-peak potential 
separation (ΔEP) between the cathodic and anodic waves as a function of 
the scan rate was investigated (figure 53). 
At low scan rates, ΔEP were close to nil but nonzero (40 mV). This unusual 
quasi-reversibility observed at low scan rates, under conditions where the 
electron transfer is not rate limiting, was previously noticed with 
immobilized proteins (Armstrong et al., 2000). Upon increasing the scan 
rate, the peak-to-peak potential separation is increased, reflecting the 
progressive kinetic control by the rate of electron transfer to the heme 
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centers. From the shift of the peak potentials as a function of the scan rate, 
the heterogeneous electron transfer rate constant ks was determined by 
fitting the resulting trumpet plots to the theoretical curves calculated from 
the classical Butler−Volmer equations, under thin-layer conditions (Léger 
and Bertrand, 2008). Using a charge-transfer coefficient of α= 0.5, the best 
fits gave ks=4s−1. This ks value, is significantly lower than the one deduced 
for MP-11 (ks=10 s-1), thus suggesting a relatively slower heterogeneous 
electron transfer in Mimochrome-ITO system. 
  
Figure 53 Trumpet plots obtained from the anodic and cathodic peak potentials in DCVAs (sp) and 
CVs (el) as a function of scan rate.  Experimental pints are referred to two different ITO electrodes 
(1 and 2) functionalized with Mimochrome VI. 
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4.8 Mimochrome VI-ITO: catalytic reduction of O2 
In order to assess Mimochrome VI-ITO catalytic properties, the reduction 
of dioxygen molecule was explored (figure 54). In the presence of O2, the 
shape of cyclic voltammograms is notably changed. In fact, the cathodic 
reversible wave that was detected in argon saturated solution, is  converted 
into a strongly enhanced irreversible reduction peak, which is positively 
shifted. Such a behavior is typical of an irreversible process, associated to 
the reduction of dioxygen, which is consequent to Fe(II) formation in the 
ITO network. This interesting catalytic property of Mimochrome VI 
represents a good starting point for the study of  the mechanism of this 
enzymatic reaction, which will allow to elucidate the number of electrons 
and the type of intermediates involved, as it was reported for MP-11, in the 
same analytical system (Renault et al., 2012). 
 
Figure 54 CVs recorded at 200 mV/s for  Mimochrome VI-ITO electrode in saturated Ar (black) 
and O2 solutions. 
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Discussion 
In this part of the PhD research activity (developed in collaboration with 
LEM laboratories), the complete spectroelectrochemical characterization of 
Mimochrome VI, immobilized on ITO electrodes, was performed to 
elucidate its thermodynamic and kinetic properties. 
Regarding the spectroscopic data, it was concluded that the spin and 
coordination states of Mimochrome VI were not affected by the 
immobilization on ITO electrodes. The unmodified  spectroscopic 
properties are a fundamental point for allowing the spectroelectrochemical 
characterization of the system. In particular, the resonance raman spectra of 
Mimochrome VI, that were practically the same for the molecule in solution 
and immobilized on ITO, were very interesting for the position of the 
marker bands in the 1300-1700 cm-1 region. The detected υ4 and υ3 
resonance bands are typically ascribed to high spin state (HS) porphyrin, 
both in heme-protein and in porphyrin models (Weiss et al., 2006). In 
particular, the frequencies of the spin-state marker υ3 occur in heme 
proteins around 1480 cm-1 for six- coordinate HS, around 1490 cm-1 for 
five-coordinate HS, and in the range of 1500-1510 cm-1 for six-coordinate 
low spin state (LS) (Reczek et al., 1989).  
The interpretation of the position of the υ2 and υ10 skeletal bands is more 
difficult, since they fall within regions at higher resonance frequencies than 
those typically found for purely HS heme proteins. This could be reasonably 
attributed to the structural differences between deuteroporphyrin (which 
characterizes Mimochrome VI structure) and protoporphyrin (which is 
typically found in natural heme- proteins). In order to verify if this hybrid 
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RR spectra is achievable to the heme cofactor chemical differences, a 
comparison with other deutero-hemin-peptide system is required. Regard 
this, Fe(III) Mimochrome IV, which is a fully characterized  six-coordinated 
LS model, will be  analyzed by RR spectroscopy (Costanzo et al., 2004; 
Lombardi et al., 2003). Another possibility could be represented by a spin-
state admixture (S=3/2, 5/2), according to Maltempo and coworkers 
quantum mechanical theory (Maltempo, 1976a, 1976b; Weiss et al., 2006). 
This model was elaborated in order to explain  some spectroscopic and 
magnetic properties of heme proteins and heme models, which were not 
adequately described by high spin (S=1/2), low spin (S=5/2) or mid spin 
(S=3/2) states. According to the S=3/2,5/2 quantum mechanical spin state 
admixture, when the energy separation of the mid-spin and high-spin states 
approaches the magnitude of the spin orbit coupling parameter, the 
electronic ground state of the heme is best described as a quantum 
mechanical admixture of these two spin states. Based on resonance Raman, 
EPR, NMR, and electronic spectra, several class III peroxidases (Howes et 
al., 1999, 2001), cytochrome c’ (Weiss et al., 2006) and some heme models 
complexes (Kadish et al., 2000) are well-described by this model.  
However, this preliminary discussion about the spin state of Fe(III) 
Mimochrome VI represents an interesting starting point for  a further 
spectroscopic characterization by resonance raman spectroscopy,  in order 
to deepen the comprehension of its structural and functional features.  
Concerning the spectroelectrochemical characterization of the 
heterogeneous electron transfer, it was found that the apparent standard 
potential of Mimochrome VI immobilized on ITO electrode was 
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substantially in agreement with that previously observed (Ranieri et al., 
2010). This confirms that all the Mimochrome VI properties were not 
modified by the presence of the metal oxide matrix. 
Some deviations from the ideal-system, described by the Nernst model were 
observed during spectroelectrochemical studies, such as the large fwhm and 
low napp values. Moreover, a very low value for the heterogeneous electron 
transfer rate constant (ks) was observed. As previously documented in a 
comparing study about neuroglobin and cytochrome c immobilized on ITO 
electrodes, this would suggest a random adsorption of Mimochrome VI in 
the film network (Schaming et al., 2012). In fact, the heterogeneity of 
microenvironment around the accessible deuteroheme pocket would lead to 
a dispersion of the apparent E°’, which could be affected by the presence 
and the number of -OH groups in the network. Moreover, the random 
orientation of Mimochrome VI could lead to a distribution of distances 
between the heme center and the conductive surface, thus justifying the 
observed ks value. 
Finally, the ability of Mimochrome VI- ITO to reduce electrocatalitically 
dioxygen was explored. The preliminary results about the catalysis are 
encouraging, and will lead to a more detailed study of its mechanism in 
order to open the way of Mimochrome VI application in electrochemical 
biosensor development. 
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5. Mimochrome VI as reporter enzyme for antibodies in  
the development of new ELISA 
The research activity of this project was also focused on the biotechnolo-
gical applications Fe(III) Mimochrome VI. On the basis of its peroxidase-
like catalytic activity, this heme-protein model is here proposed as reporter 
enzyme for the functionalization of antibodies usable in immunochemical 
assays (e.g. ELISA).  
As previously stressed, Mimochrome VI small dimensions (3.5 kDa) and its 
high catalytic efficiency make it a suitable reporter enzyme for antibodies 
conjugation. In fact, the reduced steric hindrance during the cross-linking 
reactions allow to considerably increase the conjugation ratio 
enzyme/antibody (figure 55). This is an important aspect to analyze, since 
antibodies with a high number of linked enzyme are more powerful probes 
for the detection of analytes (Chunglok et al., 2011; Iijima et al., 2010; Nara 
et al., 2008; Zhou et al., 2011). The consequent decrease of the limit of the 
detection of immunochemical techniques could make possible the easy and 
reliable detection of analytes and to reduce the costs of these immune-
chemical assays. More sensitive assays would make possible to early detect 
pathologies, which are difficult to diagnose (e.g. celiac disease), to reduce 
the number of false-positive or false-negative results, and to conduct a 
reliable follow-up of patients (Vermeersch et al., 2012).   
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Figure 55 Schematic representation of the enzyme-antibody conjugates obtained by using HRP (≈44 
KDa) and Mimochrome VI (3.5 KDa). 
5.1 Antibodies: structure and function 
Antibodies are immune system-related glicoproteins, which belong to 
immunoglobulin superfamily. These biomolecules are usually secreted by a 
type of white blood cell (B plasma cells), in order to specifically interact 
with foreign organisms (e.g. virus or bacteria) for protecting the host from 
their invasion.  
An antigen, or immunogen, is a substance, which is able to elicit this 
immune response and it is usually recognized and strongly bound by 
immonoglubilins. Antibodies are typically able to recognize a sequence as 
small as 5-6 amino acids in length (Mikol et al., 2006). The discrete chemical 
and structural molecular portion of the antigen, which is involved in this 
recognition/binding mechanism, is called epitope. According to the antigen 
dimension, a variable number of epitopes can be exposed on its surface. 
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Each epitope is usually recognized by a single type of antibody. These 
immunoglobulins are called  monoclonal and they are selected by immune 
system for their binding capability, directed against a discrete epitopic target. 
When a non-self molecule is recognized by immune system, the humoral 
response is elicited to the production of polyclonal antibodies, which 
hence can recognize and bind different parts of the antigen. Once this first 
step of immune response is realized, a set of complex effector processes 
takes place, in order to inactivate the non-self invasion. The complete 
picture of the immune system is much more complex than described, but its 
complete description is beyond the aims of this discussion. For more 
detailed information about immuno-biology, please refer to bibliography 
(Boehm, 2012; Borghesi and Milcarek, 2006; Janeway, 2005; Litman et al., 
1993) 
Antibodies can be classified into five subclasses (isotypes): IgG, IgM, IgA, 
IgE and IgD, which can be monomeric or oligomeric, and which have 
specific functions in the humoral immune response (figure 56) (Chen et al., 
2009; Geisberger et al., 2006; Pier and Lyczak, 2004; Underdown and Schiff, 
1986). 
The IgD, IgE and IgG antibody classes are each made up of a single 
structural unit, which will be described afterward (figure 57). IgDs mainly 
act as antigen receptors on B cells and they are able to activate basophiles 
and mast cells to produce antimicrobial factors. IgEs usually bind to 
allergens and triggers histamine release from mast cells and basophiles, and 
are involved in allergy. IgGs are the most abundant immunoglobulins, 
which can be detected in serum, as they provide the majority of antibody-
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based immunity, against invading pathogens. Moreover, they are the only 
antibody isotope capable of crossing the placenta to give passive immunity 
to the fetus. 
IgA antibodies may contain either one or two units, and they are usually 
found in mucosal areas (e.g. gut, respiratory and urogenital tract) and 
biological fluids (e.d. saliva, tears, and breast milk) and they prevent 
pathogens colonization.  
IgM antibodies are pentameric made up of five disulfide-linked structural 
units. These class of immunoglobulins, usually produced as monomers and 
secreted as pentamers, are involved in the first humoral response, before the 
other immunoglobulins are sufficient to proceed the immune reaction.  
 
Figure 56 General structures of immunoglobulins  isotypes. 
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The basic structure of these monomers and oligomers is well described by 
IgGs isotypes (figure 57). These immunoglobulins consists of four poly-
peptide chains, composed by two identical heavy (H) chains and two 
identical light (L) chains. H and L chains are joined together by non 
covalent interaction, as well as disulfide bridges, to form a typically Y-
shaped molecule. Depending on the class of immunoglobulin, the molecular 
weight of the heavy subunits ranges from about 50000 to around 75000 Da. 
The two light chains of an antibody have a molecular weight of about 25000 
Da. For IgG molecules, the intact molecular weight, representing all four 
subunits, is in the range of 150000-16000 Da (Greg T. Hermanson, 2008). 
The N-terminal domain, at the tip of the arms of the “Y”, on both the light 
and the heavy chain, are known to be variable in their amino acid sequence. 
Thus, they are referred as variable regions (VL and VH). The subdomains 
of the H chain are made up of three C regions (CH1, CH2, CH3) and one V 
region (VH). The L-chain, on the other hand, consists of one C region (CL) 
and one V region (VL). The base of the Y shaped antibodies is called Fc 
fragment (fragment that crystallizes) and is formed by the association of the 
two CH2 and two CH3 domains. Each arm of the Y shape is referred to as 
Fab fragment (fragment containing the binding site) and is formed by the 
association of CH1 with CL and VH with VL  (figure 57).  
The binding site (paratope) of the antibodies is located within the VH  and 
VL domains, each arm containing one binding site. In the variable regions, 
amino acid sequences can considerably vary from one  antibody to another. 
Certain regions within the V regions have very high amino acid residue 
variability. These regions are called hypervariable regions, also known as 
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complementary determining regions (CDRs). Three CDRs are integrated 
into the L-chain and three into the H-chain  resulting in six CDRs for each 
arm (Al-Lazikani et al., 1997; North et al., 2011; Putnam et al., 1979). The 
binding site has affinity for the antigen epitopes, resulting  to both structural 
complementary, as well as combination of van der Waals, ionic, 
hydrophobic and hydrogen forces. 
 
 
Figure 57 Detailed structure of an IgG antibody molecule. 
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5.2 Preparation of Antibody-Enzyme conjugates  
The unique structural features of antibodies supply a number of choices for 
modification and conjugation reactions.  
IgGs are the most commonly used in immunochemical assays and sensor 
applications, because of their easy production by immunization of 
laboratory animals. The chemistry used to effect conjugate formation 
should be selected in order to retain as much as possible the antigen binding 
activity (Greg T. Hermanson, 2008). 
Antibodies possess a number of functional groups which are suitable for 
modification and conjugation purposes. Cross-linking reagents may be used 
to target lysine ε-amine or N-terminal ends, as well as aspartic and glutamic 
acid residues. In figure 58 A the example of a N-hydroxy succini-mide-
activated enzyme, for the formation of an amide bond with antibody lysine 
residues, is showed (details about the chemistry of these reactions will be 
described after). Lys, Asp an Glu residues are usually targeted in 
conjugation procedures, since they are quite plentiful, in the antibodies 
primary structure, as well as uniformly distributed within their three-
dimensional structure. This approach is usually adopted when a high 
conjugation ratio is desired for research purposes.  
“Site-directed” methodologies can be applied for milder functionalization, 
in order to better preserve the native structure of the recognition portion of 
antibodies. Site-directed chemical modifications schemes makes use of 
cross-linking reagents that specifically react with some residues, that are 
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located in precise portion of immunoglobulin surface (Greg T. Hermanson, 
2008). 
 One example of site-directed modification is the one focused on the 
disulfides in the hinge regions, which hold the heavy chain together and that 
can be selectively cleaved with reducing agents (e.g. dithionite, etc). In this 
way, it is possible to create two half antibody molecules, each containing 
free -SH groups and non-denatured recognition regions. This free 
sulphydryl groups can be used to cross-link enzymes which exposes groups 
reactive towards -SH (e.g. maleimide activated enzymes for the formation of 
tioether bond) (figure 58 B) (Sun et al., 2005).  
A second method for the site-directed conjugation of antibodies takes 
advantage of the carbohydrate chains, which are typically attached to the 
CH2 domain within the Fc region of the immunoglobulins. Mild oxidation 
of polysaccharides sugars with sodium periodate (NaIO4) will generate 
aldheyde groups. Cross-reaction with ammine or hydrazine groups on the 
enzyme can be used for the coupling (figure 58 C).  This method usually 
results in the highest retention of antibodies binding activity within the 
conjugates. However, it can be not applied for the functionalization of both 
recombinant antibodies and hybridoma-derived preparations of monoclonal 
antibodies, since these type of immunoblobulins are usually not glycosilated 
(Greg T. Hermanson, 2008). 
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Figure 58 Examples of cross-linking reaction to couple enzymes to antibodies 
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5.3 Conjugation of Mimochrome VI to Antibodies: 
heterobifunctional cross-linkers 
In order to select the functionalization strategy for coupling Mimochrome 
VI to IgG, the category of heterobifunctional cross-linkers has been 
studied. These cross-linkers contain two different reactive groups, which 
can react with, and hence couple, different targets on proteins and other 
macromolecules (figure 59). The advantage of the use of this type of cross-
linking reagents is represented by a better control over the conjugation 
process, thus limiting polymerizations, often occurring when using 
homobifunctional linkers. Moreover, the use of heterobifunctional linkers 
provides the opportunity of multistep procedures, which allows to analyze 
the products of the reactions, that is an important aspect when protocols 
are developed. 
 
Figure 59 Scheme of a general crosslinking agent: the two differently reacting groups are separated 
by an organic cross-bridge, whose molecular structure can be designed in order to introduce spacer 
arms, which can differ for length and chemical composition. 
Reactive groups of this class of reagents are quite heterogeneous and they 
can be selected on the basis of the structural characteristics of the coupling 
molecules. The spacer-arm  has an important role in conjugates properties, 
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since it can be selected on the basis of its length, but also for its chemical 
composition. In fact, it can influence the overall hydrophobicity of the 
cross-linkers or even their chemical stability. Finally, the spacer arm can 
contain cleavable groups within their structure, thus allowing the selective 
disruption of the conjugates and lending flexibility to the experimental 
design (Greg T. Hermanson, 2008)  
5.3 a Conjugation strategy: Antibodies and SATA linker 
Polyclonal human IgG were used to develop the cross-link procedures. The 
selected chemical target for antibodies functionalization was the ε-amine 
group of lysine residue. As previously stressed, this amino acid is quite 
represented in the primary structure of antibodies and it is rather exposed 
on the surface of these glycoprotein, being a good target for 
functionalization (figure 60).  
 
Figure 60 The solvent accessibility of lysine residues  in the Fc region of an antibody is illustrated by 
high lightening Lys groups in solid gray (Greg T. Hermanson, 2008). 
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In order to introduce a large number of 
hexogen -SH groups on Lys side chain of 
IgGs, the N-succinimidyl S- acetylthio-acetate 
(SATA) was selected for the first step of the 
conjugation (figure 61) (Duncan et al., 1983).  
The reactive N-hydroxysuccinimide (NHS) ester end of the SATA linker 
reacts with amino groups in antibodies to form stable amide linkage. The 
modified antibodies contain protected sulphydryl groups, which can be 
deprotected, by adding an excess of hydroxylamine (figure 62). SATA is 
often used to form antibody-enzyme conjugates, since the protecting groups 
of the linker can be removed without adding disulfide reducing agents (e.g. 
DTT), which could affect indigenous disulfide bridges and, hence, im-
munoglobulins native structure. In fact, conjugates obtained using SATA 
have the important advantage to maintain, within conjugates, the bivalent 
nature of antibodies, which retains both the antigen binding sites. SATA 
activated immunoglobulins are generally suitable for cross-linking with 
maleimide-activated proteins. 
This first reaction step needs to be performed in slightly basic pH condition 
(pH 9), in order to maintain Lys amine groups in -NH2 form. By the use of 
the colorimetric Kaiser test for the free amine groups measurements, it was 
possible to estimate that about 50 Lys can be functionalized by SATA linker 
in the used experimental conditions (details in materials and methods). 
 
 
Figure 61 SATA linker molecular 
structure 
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Figure 62 Activation reaction of antibodies with SATA linker. 
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5.3 b Conjugation strategy: Mimochrome VI and sulfo -
SMCC linker 
Mimochrome VI has in its primary structure a Lys residue which can be 
functionalized with a heterobifunctional linker. The sulfo SMCC, succini-
midyl-4-(N-Maleimidomethyl)-cyclohexane-1-carboxylate, has been widely 
used in crosslinking proteins, in particular for the preparation of antibody-
enzyme and hapten-carrier conjugates (Dewey et al., 1987; Greg T. 
Hermanson, 2008; Hashida and Ishikawa, 1985) (figure 63).  
The NHS ester reacts with primary 
amine groups, to form stable amide 
bonds, while the maleimide end is 
specific for coupling with sulphydryls 
in the pH range of 6.5-7.5 (Smyth et 
al., 1964).  
Lys11 residue on Mimochrome VI tetradecapeptide chain was modified 
activated with sulfo-SMCC (sSMCC) in the second step of the cross-linking 
procedure (figure 64). The identity of the product has been ascertained by 
LC-MS analysis (figure 65). 
Figure 63 sSMCC linker molecular structure. 
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Figure 64 Activation reaction of Mimochrome VI with sSMCC linker. 
 
Figure 65 LCMS analysis of SMCC-activated Mimochrome VI. The LC analysis has been realized on 
a reverse phase HPLC column  (Vydac C18- 4.6 mm · 150 mm; 5 μm) by using an elution gradient of 
acetonitrile from 5% to 40% over 50 min ( in 0.1%  v/v aqueous TFA). The measured mass of the 
product (3770.2±0.4 u.m.a.) corresponds to the theoretical one (3771.09 u.m.a). 
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5.3 c Conjugation strategy: Mimochrome VI-SMCC and 
IgG SATA cross-linking 
The two molecules IgG-SH and SMCC-Mimochrome VI, separately 
activated, were used in the last step of the conjugation for the synthesis of 
the IgG-Mimochrome molecules. Conjugate compounds were obtained via 
thioether linkages between the afore-introduced cross-linkers (figure 66).  
 
Figure 66 Mimochrome VI- IgG conjugates 
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In order to obtain a high conjugation ratio, this reaction step has been 
performed in the presence of a molar excess of sSMCC-Mimochrome (50 
equivalents per IgG-SH equivalent). Thus, conjugates were purified through 
gel-filtration chromatography from the excess of the enzyme, and the 
analyzed by side exclusion HPLC chromatography, in order to check the 
absence of unreacted Mimochrome VI in the conjugate preparation (figure 
67). The absorbance spectrum of the purified conjugates shows a peak at 
280 nm (indicative of antibodies) and another one at 394 nm (referring to 
Mimochrome VI). The conjugation ratio, which has been estimated on the 
basis of the relative absorbance at these two wavelength, is around 13. 
 
Figure 67 Chromatogram of the purified conjugates (100 mM phosphate buffer pH 6.5). Inset: 
relative absorbance spectrum  
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Discussion 
 
On the basis of the presented results, we can conclude that Mimochrome 
VI is a good example of new synthetic reporter enzyme for the 
functionalization of antibodies. In fact, it has been successfully conjugated 
to polyclonal immunoglobulins with a high enzyme/IgG ratio (13 
Mimochome VI/IgG). The value obtained by using our heme-protein 
mimetic in the conjugation to antibodies is a very good result, considering 
the low enzyme/IgG ratio of commercially available HRP-based 
preparations, which are obtained by similar procedures (≈3 HRP/IgG).  
The purification through gel filtration chromatography allowed us to obtain 
an homogeneous preparation of IgG-Mimochrome VI conjugates. The 
absence of free and not covalently-bound Mimochrome VI was an 
important point, in order to avoid an over estimation of the conjugate 
catalytic activity in the following steps of the research project.  
Mimochrome VI-IgG conjugates retain the ability of oxidizing the ABTS, 
by using H2O2 as co-substrate. Currently, experiments on the immuno-
reactivity of these conjugates are in progress, in order to develop a definitive 
ELISA kit.  
 
CONCLUSIONS AND FUTURE PERSPECTIVES 
 
-132- 
   
Conclusion 
The research activity of this thesis project is focused on the rational design, 
synthesis, and characterization of five Mimochrome VI analogs. These 
molecules belong to a class of heme-proteins developed  by the  Artificial 
Metallo Enzyme Group of Naples. The parent compound, Fe(III)-
Mimochrome VI, is a penta-coordinated model that catalyzes the oxidation 
of several substrates by the activation of H2O2.  
In order to understand the role of the peptide chain and, and in particular 
of some amino acid residues, in the modulation of the catalytic properties of 
Mimochrome VI, the following substitutions were introduced: 
 Glu2L  in the tetradecapeptide and decapeptide chain; 
 Arg10L in the tetradecapeptide and decapeptide chain; 
 Ser6G in the decapeptide chain. 
These point substitutions were aimed to: 
 break the inter-chain ion pair between the charged residues, thus 
allowing to understand the role of these interactions and, as a 
consequence, of the involved amino acids in the properties of the 
molecule; 
 verify if the serine residue at the distal site of the heme is involved in 
the binding of substrates in the heme pocket. 
The five analogs were screened for the catalytic activity and the most 
promising, Fe(III)Mimochrome VI E2L TD, was selected for its increasing 
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in catalytic efficiency. Indeed,  this new analogue approaches the HRP 
catalytic performance (see paragraph 3.2 Mimochrome VI and its 
analogs:functional characterization). Fe(III)Mimochrome VI E2L TD 
displayed a kcat value only 8-fold lower than HRP,  in the experimental 
conditions for maximal activity for each enzyme. Moreover, the kinetic data 
showed that  Fe(III)Mimochrome VI E2L TD exhibits a catalytic efficiency 
higher than the reference molecule, Fe(III)Mimochrome VI, and is able to 
perform about 6000 turnovers, without bleaching. 
The characterization of this class of minienzymes demonstrates that their 
miniaturized structure holds essential elements for finely tuning the iron-
porphyrin peroxidase activity. This represents a very important checkpoint 
for the rational design of new and improved bio-mimetic catalysts. 
This class of bio-inspired molecules has important potentialities in 
biotechnologies, since their properties can be exploited for the construction 
of highly sensitive diagnostic tools (i.e. biosensors and immochemical 
assays). 
In this context, the spectroelectrochemical characterization of 
Fe(III)Mimochrome VI immobilized transparent GLAD ITO (indium tin 
oxide) film was performed in collaboration with the Laboratoire d’Electrochimie 
Moléculaire of Paris. This electrochemical system was characterized by cyclic 
voltammetry coupled to time resolved UV-visible absorbance spectroscopy. 
By cross-correlation between UV-visible absorption, spectroelectrochemical 
data, as well as resonance Raman spectra, it was possible to: 
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 conclude that no structural modification of the heme occurred upon 
adsorption on the metal oxide surface;  
 determine the surface concentration; 
 perform a quantitative analysis of the thermodynamics and kinetics of 
the direct interfacial electron transfer between the heme and the 
conductive ITO surface, by monitoring cyclic voltabsorptograms  and 
voltammograms; 
 interpret the heterogeneous electron transfer properties, as a 
consequence in the orientation of the redox centre in the network. 
Fe(III)  Mimochrome VI displayed a good electrocatalytic activity in the 
reduction of dioxygen, which, together with the high surface coverage of 
the electrode and the good electrochemical properties of the system, could 
allow to construct a high density electrochemical biosensor. 
Finally, Fe (III)-L-Mimochrome VI is here proposed as reporter enzyme for 
the functionalization of antibodies usable in immunochemical techniques. 
Considering its low molecular weight(3.5 kDa), it is possible to reduce the 
steric hindrance during the cross-linking reactions, thus increasing the 
conjugation ratio enzyme/antibody. By using cross-linkers, it was possible 
to obtain, to date, polyclonal IgG functionalized with about 13 molecules of 
this minienzymes. This conjugation enzyme/Ab ratio is significantly higher 
respect to the commercial immunoglobulins, which are usually linked to 3  
or 4 HRP molecules. These conjugates retain the catalytic activity, and 
immunoreactivity assays are in progress in order to develop a Mimochrome 
VI-based immunochemical assay, whose technology will be transferred to 
companies in the field of diagnostic. 
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In this respect, this project received last October one of the Start Cup 
Campania prizes, for the foundation of new Start Up Companies. 
In conclusion, the work performed during this PhD, is placed at the 
interface of basic and applied research, and it is based on the application of 
several techniques and methodologies in the field of chemistry, 
biochemistry and biology. During the research activity, the important goal 
of the selection of new synthetic, peptide-based catalysts, with improved 
properties was reached. Furthermore, on the basis of the results obtained 
for the functionalization of antibodies and those obtained from the 
spectroelectrochemical characterization of ITO electrodes, the important 
potential applications of this class of molecules were confirmed. 
 
 
  
 
 
 
 
 
 
 
Materials and 
methods 
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6. Solid phase peptide synthesis: an overview 
Since R. B. Merrifield (Nobel prize in 1984) reported on the solid phase 
chemical synthesis of peptides and small proteins, solid-phase peptide 
synthesis (SPPS) has become a widely utilized technique for the production 
of peptides and small proteins (Merrifield, R. B., 1963). The basic idea of 
the solid-phase approach involves the covalent attachment (anchoring) of 
the growing peptide chain to an insoluble polymeric support (resin); in this 
way unreacted soluble reagents can be removed simply by filtration and 
washing, without losses of the growing peptide chain. Subsequently, the 
insoluble peptide-resin is elongated by addition of α-amino- and side-chain-
protected amino acid residues in a series of addition reactions, which must 
be performed with high yields. Excess soluble reagents are used to drive 
sequential coupling and deprotection reactions to completion. The 
repetitive nature of the coupling and deprotection steps allowed the 
automation of the main steps of the SPPS methodology. 
The acid-labile Boc group or base-labile Fmoc-group are used for the N-α-
protection of amino acids. The general scheme of SPPS using Fmoc 
chemistry is illustrated in figure 68. Fmoc- protected amino acids are most 
popular in SPPS since a mild basic treatment, using piperidine, can be used 
for the Fmoc-group removal at every stage. The final cleavage and 
deprotection of the peptidyl resin is accomplished using TFA. An N-α-
derivatized amino acid is attached to an insoluble (solid) support, via a 
flexible linker. The N-α-blocking group is then removed (deprotected) and 
the amino acid-linker-support is thoroughly washed with solvent. The next 
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amino acid (which is also N-α-protected) is then coupled to the amino acid-
linker-support directly in the presence of coupling reagents. The coupling 
may also be carried out using peptides instead of single amino acids: this 
method is referred to as fragment condensation (Simmerman et al., 1982). 
After the completeness of the coupling reactions, the N-α-dipeptide (or 
oligopeptide)-linker-support is washed with the solvent.  
The deprotection/coupling cycle is repeated until the desired sequence is 
completed. The peptide-linker-support is cleaved to obtain the peptide as a 
free acid or amide, depending on the chemical nature of the linker. The 
cleavage reagent also removes the amino acid side chain protecting groups, 
which are stable to the deprotection reagent. These steps may be carried out 
either in batch process, where the support is filtered between each step, or 
in a continuous flow process, where the support is always solvated during 
reagent exchange, and the release of the protecting groups is 
spectrophotometrically monitored. 
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Figure 68 General approach to solid phase peptide synthesis using Fmoc chemistry. Peptides are 
synthesized from the C-terminus to the N-terminus by stepwise addition of  N-α-amino- and side 
chain-protected amino acid residues to an insoluble polymeric support (resins). Final cleavage of the 
peptidyl resin and side chain deprotection is achieved using TFA. 
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6.1 Solid phase synthesis of peptides 
 
All fully protected peptides were synthesized by using a peptide automatic 
synthesizer (see instrumentations), with Fmoc strategy, on a 0.2 mmol scale. 
The resin used was the super acid labile Nova Syn TG Sieber, with a 
substitution level 0.2 mmol/g (figure 69).  
 
Figure 69 Nova Syn TG Sieber resin for SPPS 
 
For the synthesis of the peptides the following amino acids were used: 
 
 Fmoc-Asp(OtBu)-OH; Fmoc-Glu(OtBu)-OH; Fmoc-Gln(Trt)-OH; 
Fmoc-Leu-OH; Fmoc-Ser(tBu)-OH; Fmoc-Lys(Mmt)-OH; Fmoc-Arg 
(Pbf)-OH (Mimochrome VI decapeptide and its analogs) 
 Fmoc-Asp(OtBu)-OH; Fmoc-Gln(Trt)-OH; Fmoc-Leu-OH; Fmoc-
His(Trt)-OH; Fmoc-Ser(tBu)-OH; Fmoc-Lys(Mmt)-OH; Fmoc-
Arg(Pbf)-OH; Fmoc-Lys(Boc)-OH; Fmoc-Ile-OH; Thr(tBu)-OH 
(Mimochrome VI tetradecapeptide and its analogs) 
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The synthetic procedure that was adopted can be schematized as follows: 
1. Deprotection step: the α- Fmoc group, was removed at the beginning 
of every cycle with a 20% piperidine solution. After deprotection, the 
resin is washed several times with NMP. 
2. Coupling: the activated Fmoc-amino acid (0.5 M HOBt in DMF 
solution) reacts with the amino-terminal group of the growing peptide 
chain, to form a peptide bond.  
3. Capping: this reaction is performed after each coupling step, using 
Ac2O/HOBt/DIEA solution in NMP. The aim of this step of the 
synthetic cycle is to block the amino groups of the growing peptides, 
which are not efficiently coupled with the last residues, in order to 
reduce the risks formation of truncated peptides and to drastically 
reduce the yield of the synthesis. 
 
Deprotection, coupling and capping steps are repeated with each 
subsequent amino acid, until the chain assembly is completed. Peptides N-
terminal amino groups are finally acetylated with Ac2O/HOBt/DIEA 
solution in NMP. At the end of the synthesis, the resin is washed several 
times with NMP and the it is dried. By measuring the resin weight, it is 
possible to estimate the yield of the synthesis on the basis of the scale used. 
In all peptides here reported, the yield of the synthesis based on the weight 
increment was ≥ 85%. 
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6.2 Mmt deprotection and cleavage of Mimochrome VI 
peptides 
 
Selective Mmt group cleavage from Lys9 side chains was needed in order to 
obtain peptides fully protected, except free Lys residues, for the following 
coupling reactions with deuteroporphyrin. 
After the final assembly on the resin, the N-ε Mmt protecting group of the 
Lys residue was removed, by repeated treatments with a solution containing 
10% acetic acid and 20% trifluoroethanol (TFE) (v/v) in CH2Cl2. Each 
deprotection step was performed by incubating the reaction mixture for 15 
min, under gentle agitation; then, the solution was filtered with a vacuum 
pump. This procedure was repeated until no yellow or red color, indicative 
of N-methyltrityl cations, were detected in the eluent.  
Subsequently, in order to release the fully protected peptide from the resin, 
3-4 resin volumes of a freshly prepared cleavage mixture (1% TFA in DCM, 
v/v) were added. The acidic mixture was incubated for 2 minutes, under 
mixing. The solution was filtered with a vacuum pump, into an ice-cold 
flask containing 2 ml of 10% pyridine/methanol (v/v). Finally, the resin was 
washed with DCM and methanol.  
This reaction was followed by Thin Layer Chromatography-TLC, by using 
as eluent the mix chloroform/methanol/acetic acid (80:18:2); each step was 
repeated until no product was detected in the collected fractions. The 
fractions containing the product were pooled and then evaporated under 
reduced pressure up to 5% of the volume.  
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Ice-cold water was added and the mixture was cooled on ice to aid 
precipitation of the protected peptide. The product was washed several 
times, with fresh cold water and centrifuged  at each step (4 min at 4°C, at 
3300 g). Therefore, it was dried under vacuum to give the crude C-terminal 
peptide amide. 
The side chain protecting groups were found to be stable in both 
deprotection and cleavage reactions. 
Peptide identity was checked via LC-MS analysis. The mobile phase was 
made up of H2O/0.1% trifluoroacetic acid (TFA) (solvent A) and 
CH3CN/0.1% TFA (solvent B) linear gradient, from 50% to 90% (solvent 
B) over 40 min, at a 0.5 mL·min-1flowrate.  
A Vydac C8 column (4.6 mm ·150 mm; 5 μm), reverse phase, was used in 
the LC-MS analysis. Decapeptides and tetradecapeptides chromatograms 
and the corresponding mass spectra are reported in figure 70, figura 71, 
while relative analytical parameters are summarized in table 9. This first 
step of the work-up are allowed to obtain  peptides with a satisfactory purity 
with ≈ 80% yield. 
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Figure 70 LCMS analysis of decapeptides deprotected of Mmt group. One single chromatographic 
peak (λ=210 nm) was detected and mass spectra were in agree with theoretical masses. 
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Figura 71 LCMS analysis of tetradecapeptides deprotected of Mmt group. One main 
chromatographic peak (λ=210 nm) was detected, whose mass spectra are in agree with theoretical 
masses. Mass spectrometry analysis allowed to identify the minor peak, with less retention time, as  
tetradecapeptides who lost a Trt protecting group. This was due to acidic elution conditions, thus 
confirming the good result of the synthesis. 
Table 9 Analytical parameters of synthesized peptides 
Peptide 
tR Theoretical mass Measured mass 
(min) (Da) (Da) 
TD 56.79 3310.25±0.8 3310.22 
D 48.58 2461.68±1.06 2462.11 
TD R10L 53.99 3013.93±2.01 3014.85 
TD E2L 55.45 3239.74±1.54 3238.15 
D R10L 46.69 2167.78±1.37 2166.74 
D E2L 49.40 2389.91±1.99 2390.04 
TD S10G 46.61 2375.67±1.15 2375.96 
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6.3 Coupling strategies of peptides to deuteroporphyrin 
After Mmt deprotection, peptides were coupled with the deuteronpor-
phyrin IX (DP IX), by following the scheme in figure 72. Mimochrome VI 
Decapeptide chain (D) was coupled to deuteroporphyrin to obtain the 
protected D-DPIX monoadduct, which was divided in three parts. One was 
coupled to Mimochrome VI tetradecapeptide (TD) to obtain the parent 
molecule. The remaining two parts were coupled to TD (E2L) and TD 
(R10L), respectively, to obtain the corresponding analogs. 
The same approach was used to construct decapeptide analogs, with the 
E2L, R10L and S6G substitutions, respectively. In this case the starting point 
was the TD-DPIX monoadduct. 
 
 
Figure 72 Synthetic strategy for Mimochrome VI and its analogs 
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The first peptide-deuteroporphyrin conjugation was realized on 0,16 mmol 
of decapeptide, or tetradecapeptide, chains (1 equivalent). This reaction was 
conducted in presence of DIEA (7 equivalents),  HATU (1 equivalent), 
deuteroporphyrin IX*2HCl (1.5 equivalents). In order to avoid the 
formation of heterodimers, this reaction was conducted in diluted solution 
(7.2∙10-5 M in DMF) and by adding drop wise the peptide to the 
deuteroporphyrin (30 adds every 2 minutes). The reaction mixture was 
stirred for 2 h at room temperature, and the pH was verified every 20 min, 
and adjusted with DIEA (pH ≈ 8.0), when necessary. The reaction was 
monitored by analytical HPLC (Vydac C8 column, using a gradient of 
acetonitrile in 0.1% aqueous TFA, 50% to 90% over 20 min, at a flow rate 
of 1.0 mL·min-1), and by TLC (eluent: chloroform/methanol  90:10, Rf = 
0.52). The analytical chromatograms were recorded at λ=210 nm (amide 
bond) and λ=400 nm (porphyrin) and they are reported in figures Figure 
73,Figure 74. The main peak that was detected was identified in the desired 
product (TD-DP IX and D-D IX monoadducts, respectively). The second 
peak corresponded to the diadduct product. The yield of this step reaction, 
evaluated on the basis of the chromatographic peaks areas, is 90% for TD-
DP IX reaction and 80 % for the D-DPIX reaction. 
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Figure 73 Analytical HPLC TD-DP IX monoadduct. The peak eluted At 28 minutes correspond to 
the desired products, while the one eluted at 34.6 minutes is identified as TD-DP IX-TD diadduct 
 
Figure 74 Analytical HPLC D-DP IX monoadduct. The peak eluted At 27.2 minutes correspond to 
the desired products, while the one eluted at 36.7 minutes is identified as D-DP IX-D diadduct 
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Once completed, the he reaction mixture was evaporated under reduced 
pressure and dried. The crude product was purified by Flash 
Chromatography, on a silica gel (230-430 mesh) column to eliminate the 
unreacted deuteroporphyrin (eluent: chloroform/methanol 90:10) . 
Therefore, the purified mono-peptide adducts were used for the second 
peptide coupling. Each coupling reaction was conducted on 1/3 mono-
adduct (0.045 mmol), in the presence of DIEA (6 eq) and HATU (1.2 eq). 
The second peptide (TDs for D-DP IX and Ds for TD-DPIX mono-
adducts) was added at 10 % molar excess respect to monoadduct amount. 
The reaction mixture (8.5∙10-3 M in DMF) was incubated at room 
temperature for a total of 2 h. The pH was checked during the reaction time 
an adjusted to 8, when necessary. The reaction progress was followed by 
TLC (eluent: chloroform/methanol 90:10, Rf = 0.65). At the end, the 
reaction mixture was evaporated under reduced pressure and dried.  
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6.4 Deprotection reactions and free base purification  
Side chain deprotection was achieved by addition of the cleavage mixture 
(94% TFA, 2.5% EDT, 1% TIS, 2.5% H2O v/v/v/v). The reaction was 
conducted under stirring, at 0 °C for 1h and at room temperature for the 
second hour. The final mixture was concentrated on a rotary evaporator to 
a volume of approximately 1-2 mL. Extraction of the scavengers and 
precipitation of the crude product was achieved by addition of cold diethyl 
ether. The mixture was centrifuged (room temperature at 3 300 g), the 
supernatant was removed and the precipitate was washed twice with three 
volumes of cold diethyl ether. The mixture was dried to remove diethyl 
ether, redissolved in water 0.1 % TFA and analyzed by LC-MS (Vydac C-18 
column, using a gradient of acetonitrile in 0.1% aqueous TFA, 5 % to 80% 
over 35 min, at at 1 mL min-1 flow rate). The crude material was then 
purified by preparative RP-HPLC (Vydac 2.2 cm C18 column at 22 mL 
min-1, using a gradient of acetonitrile in 0.1% aqueous TFA, 10% to 80% 
over 58.4 min); the pooled fractions containing the desired product were 
lyophilized, Analytical RP-HPLC and ESI-MS confirmed the expected 
molecular weight (data not shown). 
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6.5 Iron insertion and analysis of final products 
Iron ion was inserted into Mimochrome VI, and its analogs, free bases 
according to literature procedures (Buchler, J.W.,, 1979). Iron (II) acetate 
(10 molar excess) was added to a solution of pure free base in 2/3 
TFE/AcOH (v/v) (molar concentration=2.0∙10-4 M), and the reaction 
mixture was kept at 50 °C for 2 h, refluxing under nitrogen. The reaction 
was monitored by analytical HPLC. The solvent was then removed under 
vacuum, and the product was purified to homogeneity by preparative RP-
HPLC (Vydac 2.2 cm C-18 column at 22 mL min-1, using a gradient of 
acetonitrile in 0.1% aqueous TFA, 10% to 80% over 58.5 min). Pure 
products were obtained as the TFA salt (yield 48 %). Reverse phase 
analytical HPLC coupled with ESI-MS confirmed the expected molecular 
weight (figures Figure 75Figure 76). The analytical parameters of the 
obtained products (purity >90%) are summarized in table 10. 
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Figure 75 LCMS analysis of Mimochrome VI and E2L and R10L TD analogs 
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Figure 76 LCMS analysis of Mimochrome VI E2L, R10L and S6G TD analogs 
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Table 10  Analytical parameters of Fe(III) Mimochrome VI and its analogs 
Fe (III) 
complexes 
tR Theoretical mass Measured mass 
(min) (Da) (Da) 
Mimochrome 
VI 
45.59 3553.07±0.27 3552.71 
R10L TD 48.50 3508.07±0.27 3509.67 
E2L TD 49.49 3534.85±0.55 3536.75 
R10L D 48.81 3534.22±0.22 3536.75 
E2L D 50.09 3508.87±0.52 3509.67 
S10G TD 46.34 3521.07±0.47 3522.67 
 
6.6 Catalytic studies on ABTS oxidation  
The catalytic experiments were followed, by measuring the appearance of 
the products in the reaction medium. The substrates used in the catalytic 
assay was ABTS. The formation of ABTS●+ cation radical was followed by 
spectrophotometer at 660 nm (  = 1.4∙104 M-1cm-1). 
Kinetic parameters were determined by varying the H2O2 concentration by 
using fixed concentrations of the reducing substrates, and vice versa. In all 
catalytic experiments the reaction volume was 0.66 mL, the temperature was 
set at 25 °C and the reaction was followed under magnetic stirring.  
In the table 11 were reported the molar extinction coefficients used to 
determine the  species concentrations at their λmax.  
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Table 11 Optical parameters of regents used for catalytic experiments 
Species Solvent λmax (nm) ε (M
-1cm-1) 
Enzyme H2O 0.1% TFA (v/v) 389 1.10∙10
5 
H2O2 H2O 240 39.4 
ABTS H2O 340 3.66∙10
4 
HRP H2O 403 1.00∙10
5 
  
6.7 Spectroscopic Characterization 
UV-Vis spectra were recorded at 25°C (unless otherwise specified). Quartz 
cuvettes with a path length of 1.0 cm were used for most measurements. 
Wavelength scans were performed from 200 nm to 800 nm, with a 300 nm 
min-1 scan speed. All data are blank subtracted. 
CD spectra were collected at 25°C, from 260 to 190 nm at 0.2 nm intervals 
with a 20 nm min-1 scan speed, at 1 nm bandwidth and at 16 s response. In 
order to improve signal to noise ratio, spectra were averaged on 5 
accumulations. Cuvette path length of 1.0 cm was used. Sample 
concentration was 7.0∙10-6 M, in 10mM sodium phosphate buffer, pH 6.5.  
CD intensities (mdeg) are reported as molar ellipticity per residue (mdeg cm2 
dmol-1). All data are blank subtracted. 
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6.8 Spectroelectrochemical measurements 
Prior to Mimochrome VI adsorption, the ITO electrodes were carefully 
rinsed with acetone (15 minutes) ethanol (15 minutes) and Milli-Q. water 
(15 minutes) under mechanical stirring. The geometric electrode surface was 
delimited to 0.24 ± 0.1 cm2, by using nail varnish. Therefore, the ITO 
electrode was soaked in 10 mM MES buffer solution (pH 6.5) over night at 
room temperature. Adsorption procedures were conducted in a 50 μM 
Mimochrome VI solution, 10 mM MES buffer, pH 6.5, at room 
temperature. 
Spectroelectrochemical measurements were performed using a thermo-
stated homemade three-electrode spectroelectrochemical cell. The reference 
electrode is an Ag/AgCl, 3 M KCl electrode (WPI) and the counter 
electrode is a platinum wire. Cyclic voltammetric experiments were 
systematically performed under ohmic drop compensation in 1.1 mL 
electrolyte solution (90 mM MES,10 mM KPF6, pH 6.5) at 20 °C. The 
spectroelectrochemical cell was carefully degassed for 1 h by argon 
bubbling, prior to measurements. For measurements under saturated 
oxygen atmosphere, the electrochemical cell was bubbled with pure oxygen 
gas for 30 min prior to measurements, and for a further 2 min between each 
measurement. The integration time for spectrometric measurements was 
fixed to 10 ms. Depending on the time resolution required, each data point 
on a CVA or DCVA can result from the averaging of 2 or 4  spectra. All 
potentials in the text are referred to the Ag/AgCl, 3 M KCl reference (i.e., 
+0.2 V vs NHE). 
MATHERIALS AND METHODS 
 
-158- 
   
CHAPTER VI 
6.9 Resonance Raman Spectroscopic analysis  
Spectra were recorded at room temperature (20 °C) with a power of 2 mW 
at the sample. For solution samples, the microscope was equipped with a 
10× objective, resulting in an excitation power of 2 mW at the sample. The 
reported spectra correspond to the averaging of at least 10 scans, each 
recorded with a 10 s acquisition time. For the measurements on GLAD 
ITO electrodes, the microscope was equipped with a long-distance 100× 
objective and an optical ﬁlter (D1) to decrease the laser power on the 
sample to ca. 30 μW in order to avoid protein degradation. Reported 
spectra are the result of the average of typically 16 single spectra, each 
recorded with 5 s acquisition time. Measurements were performed from 
experiment to experiment on different surface areas to limit protein 
degradation.  
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6.10 Cross-linking procedures 
The cross-linking procedure for Mimochrome-IgG conjugation are realized 
in three steps. 
1. Maleimide-activation of Fe(III)-Mimochrome VI: 
Fe(III)-Mimochrome VI was dissolved in 0.1 M phosphate buffer, pH 7. (2 
mg of in 800 μL). Sulfo-SMCC solution is prepared immediately before use 
(4.3 mg in 100 μL acetonitrile, 200 μL water). Dissolved linker was added to 
Mimochrome VI and reaction was incubated under stirring, at room 
temperature for 1.5 hours. This reaction uses a 20:1 molar ratio of sulfo-
SMCC to protein, even if Mimochrome VI has only one free primary 
amino-group. The acylation reaction to primary amines and the hydrolysis 
(inactivation) of these NHS-ester reagent occurs rapidly at pH ≥7. For this 
reason, procedures for modification with sulfo-SMCC involve addition of a 
molar excess of reagent. Reaction was controlled with an LC-MS. Reaction 
mixture was the purified from the excess of linker by desalting column 
(PD10 equilibrated with reaction buffer). Purified colored fractions were 
pooled and, if necessary, lyophilized or frozen to preserve maleimide 
activity. Otherwise it was immediately used for covalent binding to 
antibodies. 
2. Sulfhydryl modification of Antibody with SATA 
Antibodies were purchased in phosphate buffer (0.1 M), NaCl (0.15 M), pH 
7, while the reaction of functionalization directed to lysine residues must be 
realized at slightly basic pH, because of Lys side chain pKa (≈10). For this 
reason buffer was exchanged with 0.1 M carbonate buffer, pH 9, by using 
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desalting column (Bio-Spin 6) and the final concentration of antibodies was 
1 mg/ml. SATA solution was prepared immediately before use in 
acetonitrile. A 500-fold molar excess of SATA was added to antibody and 
the reaction was incubated at room temperature for 30 minutes, under 
stirring. Free amine functionalization was checked performing a Kaiser test 
on the antibody solution before and after modification with SATA. The 
Kaiser test is colorimetric test which allows to detect the presence or 
absence of free primary amino groups, and it can be a useful indication 
about the completeness of a coupling step. The test is based on the reaction 
of ninhydrin with primary amines, which gives a characteristic dark blue 
color. This test requires minimal amounts of analyte and is completed 
within a few minutes (Kaiser et al., 1970). Comparing the colorimetric 
signal, indicative of free amines, before and after SATA functionalization, it 
was possible to estimate the number of functionalized lysine residues (≈50). 
Subsequently, the deacetylation of the SATA-modified antibodies was 
accomplished, in order to obtain free -SH groups for the last step of the 
cross-linking procedure. Thiols deprotection was conducted in the presence 
of hydroxylamine (30-fold over SATA-antibodies). The pH was checked 
and adjusted  with NaOH (pH  8), when necessary. Reaction mixture was 
then incubated for 2 hours at room temperature, under stirring. PD-10 
desalting column, (equilibra-ted with 0.1 M  phosphate, 25 mM EDTA, pH 
5) to purify the sulfhydryl-modified antibody from the hydroxylamine. 
Slightly acidic pH and EDTA were used to minimize disulfide bond 
formation (Greg T. Hermanson, 2008).  
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3. Cross-linking step 
Sulfhydryl-modified antibody which were purified by desalting procedure, 
were mixed to maleimide-activated Fe(III)-Mimochrome VI solution (molar 
ratio Mimochrome/antibody 50/1). Reaction mixture at room temperature 
for 2 hours or overnight at 4°C, on tilting plate, to avoid antibodies 
denaturation. Reaction progress was checked by HPLC, using a size-
exclusion column (Phenomenex W-Prex 5 GP 200- 250x4.6 mm size 
exclusion 1000-120000 Da) and using as eluent 0.1 M phosphate buffer, 3.5 
mM SDS, pH 6. The analytical HPLC is reported in figure 77. The first 
peak (tR 3.59 minutes) is related to Mimochrome VI-conjugated IgG, as 
confirmed by a absorption peak at 280 nm (due to antibodies aromatic 
residues) and 387 nm (due to the presence of cross-linked Mimochrome 
VI). The second peak is related to unreacted Mimochrome VI, while and 
the third on is represented by the excess of linker. 
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Figure 77 Analytical HPLC of the cross linking reaction mixture 
At the end of the cross-linking reaction, the un-conjugated Mimochrome 
was removed by gel filtration chromatography, by using a Sephadex G-100 
superfine resin (mesh 10-40), packed in a glass column 10x150 mm. 
Separation is performed in 0.1 M phosphate, pH 6.5 at a flow rate of 3 
ml/h. Purified fractions were pooled and controlled by GP-HPLC as at 
point 3 (see results and discussion section), and then stored at 4°C. 
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6.11 Materials 
All 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids, Nova Syn 
TGSieber resin and coupling reagents: N-hydroxybenzotriazole (HOBt), O-
7-Azabenzotriazol-1-yl-N,N,N’,N’’-tetramethyluronium hexafluoro-
phosphate (HATU) and benzotriazole-1-oxy-tris-pyrrolidino-phospho-nium 
hexafluorophosphate (PyBOP) were purchased fromNovaBiochem (EMD 
Biosciences, La Jolla, CA). Silica gel 60 (230-400 mesh) was from Merck. 
Precoated silica G-60 plates, F254, were used for thin-layer chromatography 
(tlc). All solvents used in the peptide synthesis and purification were 
anhydrous and HPLC grade respectively, and were supplied by Romil. 
Piperidine and scavengers (ethanedithiol, triisopropylsilane) were from 
Fluka. N,N-Diisopropylethylamine (DIPEA), trifluoroacetic acid (TFA) 
were supplied from Applied Biosystems. N,N-dimethylformamide (DMF), 
dichloromethane (DCM), pyridine, ethanol, methanol and 1-methyl-2-
pyrrolidone (NMP) were supplied by Romil. Deuteroporphyrin IX was 
from Porphyrin Products. Iron(II) acetate waspurchased from Sigma 
Aldrich. TFE was supplied by Romil. All buffer solutions were made by 
using water with a HPLC  purity degree, supplied by LabScan, 
Phosphate salts (monobasic and dibasic), MES, NaCl ad SDS for the 
buffers preparation, were provided by Fluka.  
PD10 and SP6 desalting columns were purchased by GE healthcare and 
BIORAD, respectively. Antibody (polyclonal human IgG) and cross-linkers 
were purchased by Pierce. 
ITO-coated glass substrate was used as the deposition substrate (8−12 
Ω/square, Delta Technologies Ltd.   
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6.12  Instrumentation 
Protected peptides were obtained by the use of ABI 433 automatic peptide 
synthesizer. 
HPLC and LC-MS analysis were performed with a Shimadzu LC-10ADvp 
equipped with an SPDM10Avp diode-array detector. ESI-MS spectra were 
recorded on a Shimadzu LC-MS-2010EV system with ESI interface, and 
Shimadzu LC-MS solution Workstation software for the data processing. A 
Q-array-octapole-quadrupole mass analyzer was used as the detector. The 
optimized MS parameters were selected as followed: CDL (curved 
desolvation line) temperature 250 °C; the block temperature 250 °C; the 
probe temperature 250 °C; detector gain 1.6kV; probe voltage +4.5kV; 
CDL voltage -15V. Nitrogen served as nebulizer gas (flow rate: 1.5 L·min-1). 
UV-vis analysis was performed on Cary Varian 50 Probe UV 
Spectrophotometer, while CD analysis was realized on Jasco J-715 
dichrograph. 
Time-resolved UV−visible absorption spectroscopic measurements were 
performed on a TORUS-50 diode array spectrometer (Ocean Optics) 
synchronized with a potentiostat (Autolab).  
Resonance Raman spectra were obtained with a Labram HR 800 
microspectrometer (Jobin yvon) by excitating at 405 nm with a single 
frequency collimated laser module (Ondax Inc).  
All the data were analyzed by using Origin Pro8 and Kaleidagraph 
softwares.
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List of acronyms and abbreviations  
ABTS2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid)  
Abs: Absorbance  
Ac: Acetyl  
Arg: Arginine  
Asp : Aspartic acid  
Boc: t-Butoxycarbonyl  
CD: Circular dichroism  
Cys: Cysteine  
DCM: Dichloromethane  
DOSY: Diffusion-ordered spectroscopy 
DP IX:  Deuteroporphyrin IX 
DIEA: Diisopropylethylamine  
DMF: Dimethylformamide  
EDT: Ethanedithiol  
ESI-MS: Electrospray ionization mass spectrometry 
Fmoc: 9-Fluorenylmethoxycarbonyl  
Gln: Glutamine  
GluGlutamic acid  
GlyGlycine  
HATU:  N-[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N 
methylmethanaminium hexafluorophosphate N-oxide  
 -III- 
   
His: Histidine  
HOBt: N-hydroxybenzotriazole  
HRP:  Horseradish peroxidase  
Ile: Isoleucine  
Leu: Leucine  
Lys: Lysine  
MeOH: Methanol  
Mmt: Methoxytrityl  
NMP: N-Methyl-2-pyrrolidone  
NMR: Nuclear magnetic resonance  
Pbf: 2,2,4,6,7-Pentamethyldihydrobenzofurane-5-sulfonyl  
PDB  Protein Data Bank  
PyBop: Benzotriazole-1-yl-oxy-tris-pyrrolidino-phosphonium hexafluorophosphate  
Ser: Serine  
TFA: Trifluoroacetic acid  
TFE: Trifluoroethanol  
TLC: Thin Layer Chromatography  
Trt: Trityl  
Tyr: Tyrosine  
REFERENCES 
 
-IV- 
   
 
References 
 
Al-Lazikani, B., Lesk, A.M., and Chothia, C. (1997). J. Mol. Biol. 273, 927–
948. 
Akerfeldt, K.S., Kim, R.M., Camac, D., Groves, J.T., Lear, J.D., and 
DeGrado, W.F. (1992). Journal of the American Chemical Society 114, 
9656–9657. 
Armstrong, F.A., Camba, R., Heering, H.A., Hirst, J., Jeuken, L.J., Jones, 
A.K., Léger, C., and McEvoy, J.P. (2000). Faraday Discuss. 191–203; 
discussion 257–268. 
Arnold, P.A., Benson, D.R., Brink, D.J., Hendrich, M.P., Jas, G.S., 
Kennedy, M.L., Petasis, D.T., and Wang, M. (1997). Inorganic Chemistry 
36, 5306–5315. 
Aron, J., Baldwin, D.A., Marques, H.M., Pratt, J.M., and Adams, P.A. 
(1986). Journal of Inorganic Biochemistry 27, 227–243. 
Arya, S.K., Solanki, P.R., Datta, M., and Malhotra, B.D. (2009). Biosensors 
and Bioelectronics 24, 2810–2817. 
Ashley, K., Biagini, R.E., Smith, J.P., Sammons, D.L., Mackenzie, B.A., 
Striley, C.A.F., Robertson, S.K., and Snawder, J.E. (2008). J Occup Environ 
Hyg 5, D25–32. 
Astuti, Y., Topoglidis, E., Briscoe, P.B., Fantuzzi, A., Gilardi, G., and 
Durrant, J.R. (2004). Journal of the American Chemical Society 126, 8001–
8009. 
Astuti, Y., Topoglidis, E., Cass, A.G., and Durrant, J.R. (2009). DAnalytica 
Chimica Acta 648, 2–6. 
Astuti, Y., Topoglidis, E., and Durrant, J.R. (2011). Analytica Chimica Acta 
686, 126–132. 
REFERENCES 
 
-V- 
   
Azevedo, A.M., Martins, V.C., Prazeres, D.M.F., Vojinović, V., Cabral, 
J.M.S., and Fonseca, L.P. (2003). Biotechnology Annual Review, (Elsevier), 
pp. 199–247. 
Azevedo, A.M., Prazeres, D.M.F., Cabral, J.M.S., and Fonseca, L.P. (2005). 
Biosensors and Bioelectronics 21, 235–247. 
Baltzer, L. (1999). In Implementation and Redesign of Catalytic Function in 
Biopolymers, P.D.F.P. Schmidtchen, L. Baltzer, A.R. Chamberlin, K.A. 
McDonnell, M. Famulok, M.A. Gilmore, B. Imperiali, A. Jenne, M. 
Shogren-Knaak, and L.E. Steward, eds. (Springer Berlin Heidelberg), pp. 
39–76. 
Baltzer, L., Nilsson, H., and Nilsson, J. (2001). Chem. Rev. 101, 3153–3164. 
Benson, D.R., Hart, B.R., Zhu, X., and Doughty, M.B. (1995). Journal of 
the American Chemical Society 117, 8502–8510. 
Berglund, G.I., Carlsson, G.H., Smith, A.T., Szöke, H., Henriksen, A., and 
Hajdu, J. (2002). Nature 417, 463–468.  
Bernad, S., Leygue, N., Korri-Youssoufi, H., and Lecomte, S. (2007). Eur. 
Biophys. J. 36, 1039–1048. 
Bertini, I., and Luchinat, C. (1999). Curr Opin Chem Biol 3, 145–151. 
Boehm, T. (2012). Curr. Biol. 22, R722–732. 
Bongiovanni, C., Ferri, T., Poscia, A., Varalli, M., Santucci, R., and Desideri, 
A. (2001). Bioelectrochemistry 54, 17–22. 
Borghesi, L., and Milcarek, C. (2006). Immunol. Res. 36, 27–32. 
 
Bourbonnais, R., Leech, D., and Paice, M.G. (1998). Biochimica Et 
Biophysica Acta (BBA) - General Subjects 1379, 381–390. 
Buchler, J.W., (1979). In  The  Porphyrins. In The Porphyrins, Volume 1, 
(NY, USA), pp. 389–483. 
REFERENCES 
 
-VI- 
   
Bushnell, G.W., Louie, G.V., and Brayer, G.D. (1990). J. Mol. Biol. 214, 
585–595. 
Cass, A.E.G., Davis, G., Francis, G.D., Hill, H.A.O., Aston, W.J., Higgins, 
I.J., Plotkin, E.V., Scott, L.D.L., and Turner, A.P.F. (1984). Analytical 
Chemistry 56, 667–671. 
Chan, M.K. (2000). Journal of Porphyrins and Phthalocyanines (JPP) 04, 
358–361. 
Chan, M.K. (2001). Curr Opin Chem Biol 5, 216–222. 
Chapman, S.K., Daff, S., and Munro, A.W. (1997). In Metal Sites in 
Proteins and Models, H.A.O. Hill, P.J. Sadler, and A.J. Thomson, eds. 
(Berlin, Heidelberg: Springer Berlin Heidelberg), pp. 39–70. 
Chaubey, A., and Malhotra, B.D. (2002). Biosensors and Bioelectronics 17, 
441–456. 
Chen, K., Xu, W., Wilson, M., He, B., Miller, N.W., Bengtén, E., Edholm, 
E.-S., Santini, P.A., Rath, P., Chiu, A., et al. (2009). Nat. Immunol. 10, 889–
898. 
Childs, R.E., and Bardsley, W.G. (1975). Biochem. J. 145, 93–103. 
Choma, C.T., Lear, J.D., Nelson, M.J., Dutton, P.L., Robertson, D.E., and 
DeGrado, W.F. (1994). Journal of the American Chemical Society 116, 856–
865. 
Chunglok, W., Wuragil, D.K., Oaew, S., Somasundrum, M., and 
Surareungchai, W. (2011). Biosensors and Bioelectronics 26, 3584–3589. 
Collings, A.F., and Caruso, F. (1997). Reports on Progress in Physics 60, 
1397–1445. 
Collman, J.P. (1997). Inorganic Chemistry 36, 5145–5155. 
Collman, J.P., Zhang, X., Lee, V.J., Uffelman, E.S., and Brauman, J.I. 
(1993). Science 261, 1404–1411. 
REFERENCES 
 
-VII- 
   
Cornish-Bowden, A. (2004). Fundamentals of enzyme kinetics (London: 
Portland Press). 
Crane, B.R., Siegel, L.M., and Getzoff, E.D. (1995). Science 270, 59–67. 
D’Auria, G., Maglio, O., Nastri, F., Lombardi, A., Mazzeo, M., Morelli, G., 
Paolillo, L., Pedone, C., and Pavone, V. (1997). Chemistry - A European 
Journal 3, 350–362. 
DeGrado, W.F., Summa, C.M., Pavone, V., Nastri, F., and Lombardi, A. 
(1999). Annu. Rev. Biochem. 68, 779–819. 
Del Gatto G. (2007). Synthesis and structural characterization of artificial 
metalloproteins. PhD Thesis in Chemical Sciences, XX Cycle, , 2007. 
University  of Naples “Federico II.” 
Dewey, R.E., Timothy, D.H., and Levings, C.S. (1987). Proc. Natl. Acad. 
Sci. U.S.A. 84, 5374–5378. 
Dolphin, D. (1979). The porphyrins Vol. 7, Biochemistry, Part B. (New 
York [etc.]: Academic Press). 
Domínguez, R., Serra, B., Reviejo, A.J., and Pingarrón, J.M. (2001). Anal. 
Biochem. 298, 275–282. 
Dong, S., Niu, J., and Cotton, T.M. (1995). In Methods in Enzymology, 
(Elsevier), pp. 701–732. 
Duffy, S.L., and Murphy, J.T. (2001). BioTechniques 31, 495–496, 498, 
500–501. 
Duncan, R.J., Weston, P.D., and Wrigglesworth, R. (1983). Anal. Biochem. 
132, 68–73. 
Fasman, G.D. (1996). Circular dichroism and the conformational analysis of 
biomolecules (New York: Plenum Press). 
Fattakhova-Rohlfing, D., Brezesinski, T., Rathouský, J., Feldhoff, A., 
Oekermann, T., Wark, M., and Smarsly, B.M. (2006). Advanced Materials 
18, 2980–2983. 
REFERENCES 
 
-VIII- 
   
Geisberger, R., Lamers, M., and Achatz, G. (2006). Immunology 118, 429–
437. 
Gajhede, M., Schuller, D.J., Henriksen, A., Smith, A.T., and Poulos, T.L. 
(1997). Nature Structural Biology 4, 1032–1038. 
Gibney, B.R., and Dutton, P.L. (1999). Protein Science 8, 1888–1898. 
Gibney, B.R., Isogai, Y., Rabanal, F., Reddy, K.S., Grosset, A.M., Moser, 
C.C., and Dutton, P.L. (2000) Biochemistry 39, 11041–11049. 
Goldberg, M., Dunning, S., and Bunn, H. (1988). Science 242, 1412–1415. 
Gouterman, M. (1961).  Journal of Molecular Spectroscopy 6, 138–163. 
Gray, H.B., and Winkler, J.R. (1996). Annual Review of Biochemistry 65, 
537–561. 
Green, A.N.M., Palomares, E., Haque, S.A., Kroon, J.M., and Durrant, J.R. 
(2005). The Journal of Physical Chemistry B 109, 12525–12533. 
Greg T. Hermanson (2008). Bioconjugate techniques 2nd edition. 
Griffiths, D. (1993). Trends in Biotechnology 11, 122–130. 
Gündoğan-Paul, M., Çelebi, S.S., Özyörük, H., and Yıldız, A. (2002). 
Biosensors and Bioelectronics 17, 875–881. 
Harbury, H.A., and Loach, P.A. (1959). Proc. Natl. Acad. Sci. U.S.A. 45, 
1344–1359. 
Hargrove, M.S., and Olson, J.S. (1996). Biochemistry 35, 11310–11318. 
Hargrove, M.S., Wilkinson, A.J., and Olson, J.S. (1996). Biochemistry 35, 
11300–11309. 
Hashida, S., and Ishikawa, E. (1985). Analytical Letters 18, 1143–1155. 
Hellinga, H.W. (1996). Current Opinion in Biotechnology 7, 437–441. 
REFERENCES 
 
-IX- 
   
Hellinga, H.W. (1998). The construction of metal centers in proteins by 
rational design. Folding and Design 3, R1–R8. 
Hermanson, G.T. (2008). Bioconjugate techniques (Amsterdam: Academic 
Press). 
Hildebrandt, P., and Stockburger, M. (1989). Biochemistry 28, 6710–6721. 
Howes, B.D., Schiodt, C.B., Welinder, K.G., Marzocchi, M.P., Ma, J.G., 
Zhang, J., Shelnutt, J.A., and  
Holm, R.H., Kennepohl, P., and Solomon, E.I. (1996). Chemical Reviews 
96, 2239–2314. 
Smulevich, G. (1999). Biophys. J. 77, 478–492. 
Howes, B.D., Veitch, N.C., Smith, A.T., White, C.G., and Smulevich, G. 
(2001). Biochem. J. 353, 181–191. 
Huang, L.E., Ho, V., Arany, Z., Krainc, D., Galson, D., Tendler, D., 
Livingston, D.M., and Bunn, H.F. (1997). Kidney Int. 51, 548–552. 
Huy, N.T., Xuan Trang, D.T., Uyen, D.T., Sasai, M., Harada, S., and Kamei, 
K. (2005). Analytical Biochemistry 344, 289–291. 
Iwaki, M., Yakovlev, G., Hirst, J., Osyczka, A., Dutton, P.L., Marshall, D., 
and Rich, P.R. (2005). Biochemistry 44, 4230–4237. 
Jasanoff, A., and Fersht, A.R. (1994).Biochemistry 33, 2129–2135. 
Janeway, C. (2005). Immunobiology: the immune system in health and 
disease (New York: Garland Science). 
Iijima, M., Matsuzaki, T., Kadoya, H., Hatahira, S., Hiramatsu, S., Jung, G., 
Tanizawa, K., and Kuroda, S. (2010).  Analytical Biochemistry 396, 257–
261. 
Johannes Everse, Kathleen E. Everse, and Matthew B. Grisham (1991). 
Peroxidases in chemistry and biology  II (Boca Raton, Fla.: CRC Pr.). 
REFERENCES 
 
-X- 
   
Kaiser, E., Colescott, R.L., Bossinger, C.D., and Cook, P.I. (1970). 
Analytical Biochemistry 34, 595–598. 
Kadish, K.M., Smith, K.M., and Guilard, R. (2000). The porphyrin 
handbook (San Diego: Academic Press). 
Kalsbeck, W.A., Robertson, D.E., Pandey, R.K., Smith, K.M., Dutton, P.L., 
and Bocian, D.F. (1996). Biochemistry 35, 3429–3438. 
Kemp, G.L., Marritt, S.J., Xiaoe, L., Durrant, J.R., Cheesman, M.R., and 
Butt, J.N. (2009). Biochem. Soc. Trans. 37, 368–372. 
Kennedy, M.L., Silchenko, S., Houndonougbo, N., Gibney, B.R., Dutton, 
P.L., Rodgers, K.R., and Benson, D.R. (2001). J. Am. Chem. Soc. 123, 
4635–4636. 
Khan, M.J., Qayyum, S., Alam, F., and Husain, Q. (2011). Nanotechnology 
22, 455708. 
Khoa Ly, H., Sezer, M., Wisitruangsakul, N., Feng, J.-J., Kranich, A., Millo, 
D., Weidinger, I.M., Zebger, I., Murgida, D.H., and Hildebrandt, P. (2011). 
FEBS Journal 278, 1382–1390. 
Koder, R.L., and Dutton, P.L. (2006). Dalton Transactions 3045. 
Koder, R.L., Valentine, K.G., Cerda, J., Noy, D., Smith, K.M., Wand, A.J., 
and Dutton, P.L. (2006). J. Am. Chem. Soc. 128, 14450–14451. 
Koder, R.L., Anderson, J.L.R., Solomon, L.A., Reddy, K.S., Moser, C.C., 
and Dutton, P.L. (2009). Nature 458, 305–309. 
Kranich, A., Naumann, H., Molina-Heredia, F.P., Moore, H.J., Lee, T.R., 
Lecomte, S., De la Rosa, M.A., Hildebrandt, P., and Murgida, D.H. (2009). 
Physical Chemistry Chemical Physics 11, 7390. 
Krause, K.M., Taschuk, M.T., Harris, K.D., Rider, D.A., Wakefield, N.G., 
Sit, J.C., Buriak, J.M., Thommes, M., and Brett, M.J. (2010). Langmuir 26, 
4368–4376. 
REFERENCES 
 
-XI- 
   
Krzemiński, Ł., Ndamba, L., Canters, G.W., Aartsma, T.J., Evans, S.D., and 
Jeuken, L.J.C. (2011). Journal of the American Chemical Society 133, 
15085–15093. 
Kuroda, N., Murasaki, N., Wada, M., and Nakashima, K. (2001). 
Luminescence 16, 167–172. 
Lacey, A.L., Gutiérrez-Sánchez, C., Fernández, V.M., Pacheco, I., and 
Pereira, I.A.C. (2008). JBIC Journal of Biological Inorganic Chemistry 13, 
1315–1320. 
Léger, C., and Bertrand, P. (2008). Chem. Rev. 108, 2379–2438. 
Lemberg, R., and Falk, J.E. (1951). Biochem. J. 49, 674–683. 
Li, T., Bonkovsky, H.L., and Guo, J. (2011). BMC Struct. Biol. 11, 13. 
Litman, G.W., Rast, J.P., Shamblott, M.J., Haire, R.N., Hulst, M., Roess, W., 
Litman, R.T., Hinds-Frey, K.R., Zilch, A., and Amemiya, C.T. (1993). Mol. 
Biol. Evol. 10, 60–72. 
Liu, D., Williamson, D.A., Kennedy, M.L., Williams, T.D., Morton, M.M., 
and Benson, D.R. (1999a). Journal of the American Chemical Society 121, 
11798–11812. 
Liu, D., Lee, K.-H., and Benson, D.R. (1999b). Chemical Communications 
1205–1206. 
Liu, X., Huang, Y., Shang, L., Wang, X., Xiao, H., and Li, G. (2006). 
Bioelectrochemistry 68, 98–104. 
Lombardi, A., Nastri, F., Sanseverino, M., Maglio, O., Pedone, C., and 
Pavone, V. (1998). Inorganica Chimica Acta 275-276, 301–313. 
Lombardi, A., Nastri, F., and Pavone, V. (2001). Chem. Rev. 101, 3165–
3189. 
Lombardi, A., Nastri, F., Marasco, D., Maglio, O., De Sanctis, G., Sinibaldi, 
F., Santucci, R., Coletta, M., and Pavone, V. (2003). Chemistry - A 
European Journal 9, 5643–5654. 
REFERENCES 
 
-XII- 
   
Low, D.W., Yang, G., Winkler, J.R., and Gray, H.B. (1997). Journal of the 
American Chemical Society 119, 4094–4095. 
Lu, Y., and Valentine, J.S. (1997). Curr. Opin. Struct. Biol. 7, 495–500. 
Maltempo, M.M. (1976a). Biochim. Biophys. Acta 434, 513–518. 
Maltempo, M.M. (1976b). Q. Rev. Biophys. 9, 181–215. 
Mansuy, D. (1993). Coordination Chemistry Reviews 125, 129–141. 
Marritt, S.J., Van Wonderen, J.H., Cheesman, M.R., and Butt, J.N. (2006). 
Analytical Biochemistry 359, 79–83. 
Marshall, D., Fisher, N., Grigic, L., Zickermann, V., Brandt, U., Shannon, 
R.J., Hirst, J., Lawrence, R., and Rich, P.R. (2006). Biochemistry 45, 5458–
5467.Mansuy, D. (1990). Pure and Applied Chemistry 62, 741–746. 
Marques, H.M. (2007). Dalton Transactions 4371. 
McInvale, A.C., Harlan, R.E., and Garcia, M.M. (2000). Brain Research 
Protocols 5, 39–48. 
Mello, L.D., and Kubota, L.T. (2002). Food Chemistry 77, 237–256. 
Merrifield, R. B. (1963). Journal of  the American Chemical Society 85, 
2149–2154. 
Meunier, B. (1992). Chemical Reviews 92, 1411–1456. 
Mikol, D.D., Ditlow, C., Usatin, D., Biswas, P., Kalbfleisch, J., Milner, A., 
and Calenoff, E. (2006). J. Neuroimmunol. 180, 40–49. 
Momenteau, M., and Reed, C.A. (1994). Chemical Reviews 94, 659–698. 
Monien, B.H., Drepper, F., Sommerhalter, M., Lubitz, W., and Haehnel, W. 
(2007).J. Mol. Biol. 371, 739–753. 
Mulchandani, A., and Rudolph, D.C. (1995). Anal. Biochem. 225, 277–282. 
REFERENCES 
 
-XIII- 
   
Mutter, M., and Vuilleumier, S. (1989). Angewandte Chemie International 
Edition in English 28, 535–554. 
Nara, S., Tripathi, V., Chaube, S.K., Rangari, K., Singh, H., Kariya, K.P., 
and Shrivastav, T.G. (2008). Journal of Immunoassay and 
Immunochemistry 29, 390–405. 
Narula, J., Pandey, P., Arbustini, E., Haider, N., Narula, N., Kolodgie, F.D., 
Dal Bello, B., Semigran, M.J., Bielsa-Masdeu, A., Dec, G.W., et al. (1999). 
Proceedings of the National Academy of Sciences 96, 8144–8149. 
Nastri, F., Lombardi, A., Morelli, G., Maglio, O., D’Auria, G., Pedone, C., 
and Pavone, V. (1997). Chemistry - A European Journal 3, 340–349. 
Nastri, F., Lombardi, A., D’Andrea, L.D., Sanseverino, M., Maglio, O., and 
Pavone, V. (1998). Biopolymers 47, 5–22. 
Nastri, F., Lista, L., Ringhieri, P., Vitale, R., Faiella, M., Andreozzi, C., 
Travascio, P., Maglio, O., Lombardi, A., and Pavone, V. (2011). Chemistry - 
A European Journal 17, 4444–4453. 
North, B., Lehmann, A., and Dunbrack, R.L., Jr (2011). J. Mol. Biol. 406, 
228–256. 
Nuzzo, R.G., and Allara, D.L. (1983). Journal of the American Chemical 
Society 105, 4481–4483. 
Paléus, S., Ehrenberg, A., Tuppy, H., and Virtanen, A.I. (1955). Acta 
Chemica Scandinavica 9, 365–374. 
Panicco, P., Astuti, Y., Fantuzzi, A., Durrant, J.R., and Gilardi, G. (2008). 
The Journal of Physical Chemistry B 112, 14063–14068. 
Park, S.-Y., Yokoyama, T., Shibayama, N., Shiro, Y., and Tame, J.R.H. 
(2006). Journal of Molecular Biology 360, 690–701. 
Parra, A., Casero, E., Vázquez, L., Pariente, F., and Lorenzo, E. (2006). 
Analytica Chimica Acta 555, 308–315. 
Peña, N., Ruiz, G., Reviejo, A.J., and Pingarrón, J.M. (2001). Analytical 
Chemistry 73, 1190–1195. 
REFERENCES 
 
-XIV- 
   
Perutz, M.F., Wilkinson, A.J., Paoli, M., and Dodson, G.G. (1998). Annu 
Rev Biophys Biomol Struct 27, 1–34. 
Peterson, J.A., and Graham, S.E. (1998). Structure 6, 1079–1085. 
Pier, G.B., and Lyczak, J.B. (2004). Immunology, infection, and immunity 
(Washington, D.C: ASM Press). 
Poulos, T.L., and Kraut, J. (1980). J. Biol. Chem. 255, 8199–8205.  
Privalle, C.T. (1983). Proceedings of the National Academy of Sciences 80, 
702–706. 
Putnam, F.W., Liu, Y.S., and Low, T.L. (1979).. J. Biol. Chem. 254, 2865–
2874. 
Rabanal, F., DeGrado, W.F., and Dutton, P.L. (1996). Journal of the 
American Chemical Society 118, 473–474. 
Ranieri, A., Monari, S., Sola, M., Borsari, M., Battistuzzi, G., Ringhieri, P., 
Nastri, F., Pavone, V., and Lombardi, A. (2010). R Langmuir 26, 17831–
17835. 
Rau, H.K., and Haehnel, W. (1998). Journal of the American Chemical 
Society 120, 468–476. 
Rau, DeJonge, and Haehnel (2000). Angew. Chem. Int. Ed. Engl. 39, 250–
253. 
Rau, H.K., DeJonge, N., and Haehnel, W. (1998). Proc. Natl. Acad. Sci. 
U.S.A. 95, 11526–11531. 
Reedy, C.J., and Gibney, B.R. (2004). Chemical Reviews 104, 617–650. 
Regan, L. (1995). Trends in Biochemical Sciences 20, 280–285. 
Ringhieri, P. (2010). Synthetic heme-proteins in biosensor development. 
PhD Thesis in Chemical Sciences, XXIII Cycle, , 2010. 
Reczek, C.M., Sitter, A.J., and Terner, J. (1989). Journal of Molecular 
Structure 214, 27–41. 
REFERENCES 
 
-XV- 
   
Renault, C., Harris, K.D., Brett, M.J., Balland, V., and Limoges, B. (2011). 
Chemical Communications 47, 1863. 
Renault, C., Andrieux, C.P., Tucker, R.T., Brett, M.J., Balland, V., and 
Limoges, B. (2012). Journal of the American Chemical Society 134, 6834–
6845. 
Robbie, K. (1998). Journal of Vacuum Science & Technology B: 
Microelectronics and Nanometer Structures 16, 1115. 
Robertson, D.E., Farid, R.S., Moser, C.C., Urbauer, J.L., Mulholland, S.E., 
Pidikiti, R., Lear, J.D., Wand, A.J., DeGrado, W.F., and Dutton, P.L. (1994). 
Nature 368, 425–432. 
Rodriguez-Lopez, J.N., Smith, A.T., and Thorneley, R.N. (1996). J. Biol. 
Chem. 271, 4023–4030. 
Roda, A., Simoni, P., Mirasoli, M., Baraldini, M., and Violante, S.F. (2002). 
Analytical and Bioanalytical Chemistry 372, 751–758. 
Salverda, J.M., Patil, A.V., Mizzon, G., Kuznetsova, S., Zauner, G., Akkilic, 
N., Canters, G.W., Davis, J.J., Heering, H.A., and Aartsma, T.J. (2010). 
Angewandte Chemie International Edition 49, 5776–5779. 
Savenkova, M.I., Kuo, J.M., and Ortiz de Montellano, P.R. (1998). 
Biochemistry 37, 10828–10836. 
Samanta, D., and Sarkar, A. (2011). Chem Soc Rev 40, 2567–2592. 
Sasaki, T., and Kaiser, E.T. (1989). Journal of the American Chemical 
Society 111, 380–381. 
Sasaki, T., and Kaiser, E.T. (1990). Biopolymers 29, 79–88. 
Schäfer, G., Purschke, W., and Schmidt, C.L. (1996). FEMS Microbiol. Rev. 
18, 173–188. 
Schaming, D., Renault, C., Tucker, R.T., Lau-Truong, S., Aubard, J., Brett, 
M.J., Balland, V., and Limoges, B. (2012). Langmuir 28, 14065–14072. 
REFERENCES 
 
-XVI- 
   
Serra, B., Reviejo, A.., Parrado, C., and Pingarrón, J.. (1999). Biosensors and 
Bioelectronics 14, 505–513. 
Shifman, J.M., Moser, C.C., Kalsbeck, W.A., Bocian, D.F., and Dutton, P.L. 
(1998). Biochemistry 37, 16815–16827. 
Shifman, J.M., Gibney, B.R., Sharp, R.E., and Dutton, P.L. (2000). 
Biochemistry 39, 14813–14821. 
Simmerman, H.K., Wang, C.C., Horwitz, E.M., Berzofsky, J.A., and Gurd, 
F.R. (1982). Proc. Natl. Acad. Sci. U.S.A. 79, 7739–7743. 
Smyth, D.G., Blumenfeld, O.O., and Konigsberg, W. (1964). Biochem. J. 
91, 589–595. 
Somasundrum, M., Kirtikara, K., and Tanticharoen, M. (1996).  Analytica 
Chimica Acta 319, 59–70. 
Sundaramoorthy, M., Terner, J., and Poulos, T.L. (1995). Structure 3, 1367–
1377. 
Sun, M.M.C., Beam, K.S., Cerveny, C.G., Hamblett, K.J., Blackmore, R.S., 
Torgov, M.Y., Handley, F.G.M., Ihle, N.C., Senter, P.D., and Alley, S.C. 
(2005). Bioconjug. Chem. 16, 1282–1290. 
Thévenot, D.R., Toth, K., Durst, R.A., and Wilson, G.S. (1999). Pure and 
Applied Chemistry 71, 2333–2348. 
Thévenot, D.R., Toth, K., Durst, R.A., and Wilson, G.S. (2001). 
International Union of Pure and Applied Chemistry: Physical Chemistry 
Division, Commission I.7 (Biophysical Chemistry); Analytical Chemistry 
Division, Commission V.5 (Electroanalytical Chemistry).1. Biosensors and 
Bioelectronics 16, 121–131. 
Traylor, T.G. (1981). Accounts of Chemical Research 14, 102–109. 
Traylor, T.G., Chang, C.K., Geibel, J., Berzinis, A., Mincey, T., and Cannon, 
J. (1979). Journal of the American Chemical Society 101, 6716–6731. 
Tuppy, H., Paléus, S., Tuppy, H., and Virtanen, A.I. (1955). Acta Chemica 
Scandinavica 9, 353–364. 
REFERENCES 
 
-XVII- 
   
Underdown, B.J., and Schiff, J.M. (1986). Annu. Rev. Immunol. 4, 389–417. 
Vainshtein, B.K., Melik-Adamyan, W.R., Barynin, V.V., Vagin, A.A., 
Grebenko, A.I., Borisov, V.V., Bartels, K.S., Fita, I., and Rossmann, M.G. 
(1986). T J. Mol. Biol. 188, 49–61. 
Veitch, N.C. (2004). Phytochemistry 65, 249–259. 
Veitch, N.C., and Smith, A.T. (2000). In Advances in Inorganic Chemistry, 
(Elsevier), pp. 107–162. 
Venturi, M. (2012). In The Exploration of Supramolecular Systems and 
Nanostructures by Photochemical Techniques, P. Ceroni, ed. (Dordrecht: 
Springer Netherlands), pp. 209–225. 
Vermeersch, P., Geboes, K., Mariën, G., Hoffman, I., Hiele, M., and 
Bossuyt, X. (2012). Clinica Chimica Acta 413, 1761–1767. 
Vuilleumier, S., and Mutter, M. (1993). Biopolymers 33, 389–400. 
Wang, Y., Brezesinski, T., Antonietti, M., and Smarsly, B. (2009). ACS 
Nano 3, 1373–1378. 
Wang, Y., and Hasebe, Y. (2011). Electroanalysis 23, 1631–1637. 
Wang, M., Kennedy, M.L., Hart, B.R., and Benson, D.R. (1997). Chemical 
Communications 883–884. 
Weiss, R., Gold, A., and Terner, J. (2006). Chemical Reviews 106, 2550–
2579. 
Welinder, K.G. (1976). FEBS Letters 72, 19–23. 
Williamson, D.A., and Benson, D.R. (1998). Chemical Communications 
961–962. 
Whitehouse, C.J.C., Bell, S.G., Yang, W., Yorke, J.A., Blanford, C.F., 
Strong, A.J.F., Morse, E.J., Bartlam, M., Rao, Z., and Wong, L.-L. 
(2009).Chembiochem 10, 1654–1656. 
REFERENCES 
 
-XVIII- 
   
Wu, S., Bellei, M., Mansy, S.S., Battistuzzi, G., Sola, M., and Cowan, J.A. 
(2011). Journal of Inorganic Biochemistry 105, 806–811. 
Yabuki, S., Mizutani, F., and Hirata, Y. (2001). Electroanalysis 13, 380–383. 
Yang, B.Y., Gray, J.S.S., and Montgomery, R. (1996). Carbohydrate 
Research 287, 203–212. 
Yavo, B., Brunetti, I.L., Da Fonseca, L.M., Catalani, L.H., and Campa, A. 
(2001). Luminescence 16, 299–304. 
Yoshikawa, S. (2002) Adv. Protein Chem. 60, 341–395. 
Zhang, Y., He, P., and Hu, N. (2004). Electrochimica Acta 49, 1981–1988. 
Zhou, Y., Tian, X.-L., Li, Y.-S., Pan, F.-G., Zhang, Y.-Y., Zhang, J.-H., 
Yang, L., Wang, X.-R., Ren, H.-L., Lu, S.-Y., et al. (2011). Biosensors and 
Bioelectronics 26, 3700–3704. 
 
 
 
 
 
 
 
 
 
LIST OF PUBBLICATIONS AND AWARDS 
 
-XIX- 
   
F. Nastri, L. Lista, P. Ringhieri, R. Vitale, M. Faiella, C. Andreozzi, P. 
Travascio, O. Maglio, A. Lombardi, V. Pavone 
Chemistry - A european journal (2011) 17(16):4444-53 
Title. A heme-peptide metalloenzyme mimetic with natural peroxidase-like activity 
Abstract. Mimicking enzymes with alternative molecules represents an important 
objective in synthetic biology, aimed to obtain new chemical entities for specific 
applications. This objective is hampered by the large size and complexity of 
enzymes. The manipulation of their structures often leads to a reduction of 
enzyme activity. Here, we describe the spectroscopic and functional 
characterization of FeIII-Mimochrome VI, a 3.5 kDa synthetic heme-protein 
model, which displays a peroxidase-like catalytic activity. By the use of hydrogen 
peroxide, it efficiently catalyzes the oxidation of several substrates, with a typical 
Michaelis-Menten mechanism and with several multiple turnovers. The catalytic 
efficiency of FeIII-Mimochrome VI in the oxidation of ABTS and guaiacol 
(kcat/Km = 4417 and 870 mM-1·s-1, respectively) is comparable to that of native 
HRP (kcat/Km = 5125 and 500 mM-1 s-1, respectively). These results demonstrate 
that small synthetic peptide can impart high enzyme activities to metal cofactors, 
and anticipate the possibility of constructing new biocatalysts tailored to specific 
functions. 
*** 
Staiano M, Baldassarre M, Esposito M, Apicella E, Vitale R, Aurilia V, D'Auria S 
Environmental technology (2010) 8-9: 935-42 
Title. New trends in bio/nanotechnology: stable proteins as advanced molecular tools for health 
and environment 
Abstract. In this work the thermophilic trehalose/maltose-binding protein from 
Thermococcus litoralis is presented as a probe for the design of a high stable 
fluorescence biosensor for glucose. In particular, we show the possibility of 
modulating the protein specificity by changing temperature. In addition to glucose 
sensing, we also report on the possibility of utilizing odorant-binding proteins as a 
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probe for the development of optical sensors for analytes of environmental 
interests. 
*** 
This project was proposed in “InKidia” business idea and received one of the Start 
Cup Campania 2012 prizes, for the foundation of new Start Up Companies. 
 
 
 
